WO1996021482A2 - Medical injection system comprising a gas spring - Google Patents
Medical injection system comprising a gas spring Download PDFInfo
- Publication number
- WO1996021482A2 WO1996021482A2 PCT/US1996/000086 US9600086W WO9621482A2 WO 1996021482 A2 WO1996021482 A2 WO 1996021482A2 US 9600086 W US9600086 W US 9600086W WO 9621482 A2 WO9621482 A2 WO 9621482A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- piston
- gas spring
- nozzle assembly
- plunger
- chamber
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F41—WEAPONS
- F41B—WEAPONS FOR PROJECTING MISSILES WITHOUT USE OF EXPLOSIVE OR COMBUSTIBLE PROPELLANT CHARGE; WEAPONS NOT OTHERWISE PROVIDED FOR
- F41B11/00—Compressed-gas guns, e.g. air guns; Steam guns
- F41B11/60—Compressed-gas guns, e.g. air guns; Steam guns characterised by the supply of compressed gas
- F41B11/64—Compressed-gas guns, e.g. air guns; Steam guns characterised by the supply of compressed gas having a piston effecting a compressor stroke during the firing of each shot
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F41—WEAPONS
- F41B—WEAPONS FOR PROJECTING MISSILES WITHOUT USE OF EXPLOSIVE OR COMBUSTIBLE PROPELLANT CHARGE; WEAPONS NOT OTHERWISE PROVIDED FOR
- F41B11/00—Compressed-gas guns, e.g. air guns; Steam guns
- F41B11/60—Compressed-gas guns, e.g. air guns; Steam guns characterised by the supply of compressed gas
- F41B11/64—Compressed-gas guns, e.g. air guns; Steam guns characterised by the supply of compressed gas having a piston effecting a compressor stroke during the firing of each shot
- F41B11/642—Compressed-gas guns, e.g. air guns; Steam guns characterised by the supply of compressed gas having a piston effecting a compressor stroke during the firing of each shot the piston being spring operated
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F41—WEAPONS
- F41B—WEAPONS FOR PROJECTING MISSILES WITHOUT USE OF EXPLOSIVE OR COMBUSTIBLE PROPELLANT CHARGE; WEAPONS NOT OTHERWISE PROVIDED FOR
- F41B11/00—Compressed-gas guns, e.g. air guns; Steam guns
- F41B11/60—Compressed-gas guns, e.g. air guns; Steam guns characterised by the supply of compressed gas
- F41B11/64—Compressed-gas guns, e.g. air guns; Steam guns characterised by the supply of compressed gas having a piston effecting a compressor stroke during the firing of each shot
- F41B11/642—Compressed-gas guns, e.g. air guns; Steam guns characterised by the supply of compressed gas having a piston effecting a compressor stroke during the firing of each shot the piston being spring operated
- F41B11/646—Arrangements for putting the spring under tension
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F41—WEAPONS
- F41B—WEAPONS FOR PROJECTING MISSILES WITHOUT USE OF EXPLOSIVE OR COMBUSTIBLE PROPELLANT CHARGE; WEAPONS NOT OTHERWISE PROVIDED FOR
- F41B11/00—Compressed-gas guns, e.g. air guns; Steam guns
- F41B11/80—Compressed-gas guns, e.g. air guns; Steam guns specially adapted for particular purposes
- F41B11/81—Compressed-gas guns, e.g. air guns; Steam guns specially adapted for particular purposes for ejecting powder, e.g. pepper
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2006—Piercing means
- A61J1/201—Piercing means having one piercing end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/202—Separating means
- A61J1/2044—Separating means having slits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
- A61J1/2051—Connecting means having tap means, e.g. tap means activated by sliding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
- A61J1/2055—Connecting means having gripping means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2096—Combination of a vial and a syringe for transferring or mixing their contents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M5/2053—Media being expelled from injector by pressurised fluid or vacuum
Definitions
- the present invention relates to a needleless injection system for injecting medication or the like, and in particular to a needleless injection device or injector employing a gas spring to force the medication out of the injector.
- the present gas spring can be used in the needleless injector as well as other devices such as an air gun.
- the injection system also includes a disposable, quick release coupling device for coupling a medication supply vial to the needleless injector or the like.
- injectors have been contemplated to administer medication as a fine, high velocity jet, delivered under sufficient pressure to enable the jet to pass through the skin tissue without requiring a hypodermic needle.
- injectors typically have a nozzle assembly having an internal chamber for holding medication.
- the nozzle member has an orifice through which a jet stream of medication is forced out from the chamber typically using a plunger attached to an energy source, most commonly a coil spring, as described for instance in the aforementioned '830, '543 and '818 patents.
- Needleless injectors provide a relatively painless and efficient way of administering medication to a percutaneous or subcutaneous tissue zone, for example, and therefore are deemed better suited for such use.
- persons afflicted with diabetes mellitus need to take one or more daily doses of insulin to maintain an appropriate glycemic balance.
- hypodermic needle When a hypodermic needle is used, due to the natural aversion to piercing oneself with the needle, patient compliance with physician's dosage regimen can be hampered.
- a needleless injector since there is no needle, any apprehension of piercing oneself with a needle is substantially eliminated, allowing the patient to better comply with the dosage regimen.
- the needleless injector also affords a further advantage in that the medication is dispersed through a greater volume of subcutaneous tissue than when a bolus injection is introduced through a conventional hypodermic needle.
- the presently known portable needleless injectors do pose certain shortcomings. These include the inability to provide sufficient and generally substantially constant pressure over the period during which the medication is ejected from the nozzle assembly. Consequently, the medication within the nozzle assembly may not be fully injected to a target zone if the spring force is not sufficiently high throughout the injection period, which can lead to a "wet" injection.
- the aforementioned '332 patent uses a large number of axially aligned disk springs in attempting to defeat this shortcoming.
- a coil spring operated system is limited in terms of the amount of maximum force that can be exerted on the plunger for a given size thereof.
- greater force variation is desired to allow for injection of a variety of medications and doses. The known devices do not remedy the deficiencies evident in these trade offs.
- a powered vacuum- compression unit is used as an energy source. While the pressure can be regulated using such a device, the portability and size are severely compromised as a separate power supply is needed to run the vacuum- compression unit.
- a gas propellant such as a C0 2 cartridge, as described in the aforementioned '824 and '765 patents, where the C0 2 gas from the cartridge is used to propel the plunger and expel medication out of the nozzle assembly.
- the drawback with the C0 2 cartridge is that it can only generate a limited pressure range and the pressure output is highly sensitive to the ambient temperature.
- the pressure of C0 2 fluctuates with the change in the ambient temperature.
- a pressure regulator device in attempting to generate pressure necessary to force the plunger, a gas generating pyrotechnic charge is contemplated.
- the charge is detonated to produce pressurized gas acting upon the plunger.
- this type of device has many shortcomings.
- the pressure generated from the detonating charge can be unreliable in that the charge does not necessarily produce uniform pressure each time it is detonated.
- a pressurized chamber defined by the injector's main housing is further compressed manually to store energy, which is to propel the plunger.
- they have not been designed to deliver medication under substantially constant pressure throughout the injection period, suffering the same predicament of the coil operated devices.
- the present invention is drawn to a needleless injection system which includes a needleless device for injecting a medical product, in particular, to a portable hand held device for injecting a medical product into a patient.
- the present system can also include a coupling device for coupling a medication supply vial to a nozzle assembly of a needleless injection device or the like.
- the present invention is additionally drawn to an improved gas spring that can be used with devices requiring an energy source, including a needleless injector and a projectile launching device such as an air gun.
- the needleless injector comprises a nozzle assembly having an ampule chamber for holding the medical product and an energy mechanism or energy means.
- the nozzle assembly has an orifice in fluid communication with the ampule chamber for allowing passage of the medical product in and out of the ampule chamber.
- the nozzle assembly is preferably removably connected and can be prefilled with a medical product if desired or can even be of a disposable type.
- a pressure wall member preferably a plunger, is movably disposed within the ampule chamber holding the medical product.
- the energy mechanism comprises a gas spring dimensioned and configured to selectively couple to the pressure wall member, which preferably is discrete and self-contained for replaceability.
- the gas spring rapidly moves the pressure wall member and forces the medical product out of the ampule chamber at a substantially uniform pressure.
- the gas spring comprises a gas spring pressure chamber defined by a tubular sleeve and a pair of sealed ends, preferably end plugs, sealingly enclosing the tubular sleeve, and a piston extending through the end plugs and occupying a portion of the gas spring chamber.
- the gas spring chamber is pressurized with gas, preferably nitrogen.
- the piston is slidable relative to the ends or end plugs, but seals the chamber to retain the pressure in the gas spring chamber.
- the piston has a first piston portion and a second piston portion, the first piston portion being larger than the second piston portion.
- At least a part of the second piston portion occupies the gas spring chamber when the piston is at its neutral condition, where the gas spring chamber is further compressed by moving the larger first piston portion into the gas spring chamber.
- the first piston portion is at least twice the diameter of the second piston portion, although any other first to second piston portion ratio can be selected depending upon the pressure increase or spring force constant desired.
- the volume of the gas spring chamber should be sufficiently larger than the volume occupied by the piston at its full compression, preferably to about 4:1 ratio and greater.
- the energy mechanism further includes a trigger mechanism that operatively engages and disengages the coupling mechanism to hold the gas spring in its compressed condition and to release the gas spring from the compressed condition.
- the nozzle assembly and the gas spring are attached to a main housing which can be formed of any durable material capable of withstanding stress and strain subjected to, preferably a liquid crystal polymer.
- the energy mechanism further includes an actuating mechanism connected to the housing. The actuating mechanism holds the trigger mechanism and is movable relative to the housing. By engaging the coupling mechanism and moving the actuating mechanism away from the sleeve, the second piston portion is pulled out of the gas spring chamber while forcing the first piston portion into the gas spring chamber, further compressing the gas spring chamber.
- the gas spring and the trigger mechanism are contained in the housing while the actuating mechanism is movably connected to the housing.
- the nozzle assembly is connected to the actuating mechanism so as to be movable along with the actuating mechanism.
- the actuating mechanism compresses the gas spring by pushing the first piston portion into the gas spring chamber. This moves the gas spring coupling mechanism into the trigger mechanism by which the gas spring is held in the further compressed condition.
- the free end of the first piston portion is operatively connected to the plunger.
- a lost motion connection mechanism is connected between the plunger and the first piston portion to provide a predetermined free play between the plunger and the piston.
- the lost motion connection mechanism thus enables the piston to move a predetermined distance before the piston pushes the plunger into the ampule chamber.
- the lost motion connection mechanism can comprise a tubular ram having a longitudinal slot occupied by a connector shaft of the plunger, allowing the shaft to slide relative thereto.
- the shaft can have a predetermined length to provide a predetermined gap between an end of the plunger and the end of the ram. The end of the ram can engage the plunger after the gap is first closed.
- the lost motion connection mechanism can allow removable connection between the gas piston or the ram, if used, and the plunger, where one of the ends of the plunger and the first piston portion has a quick release resilient snap fitting connector and the other of the ends of the plunger and the first piston portion has a complementary engaging means such as an enlarged end or head portion or a channeled head having an enlarged head portion and an annual channel portion of a predetermined width.
- the lost motion connection mechanism according to the present may be made such that the force required to disconnect the plunger from the gas piston is substantially greater than the force required to move the pressure wall member away from said terminal wall during introduction of medication into said chamber.
- the lost motion connection mechanism such that the plunger cannot be disconnected from the gas piston or the ram, if used, without first exposing the plunger, i.e., removing the nozzle assembly.
- the connector has at least one snap fitting prong, four being preferable, each made of resilient material, which upon being attached to the enlarged head expands and returns to its original configuration once the end of the prong is connected to the enlarged head.
- a tab extends from each prong which engages a shoulder portion of the enlarged head to maintain the engagement. The entire plunger, including the prongs, is confined within the ampule chamber.
- the prongs are dimensioned to slide inside the ampule chamber, the inner wall of the chamber confines the prongs from moving laterally outwardly to maintain the piston engaged to the plunger during use.
- the plunger is disconnected from the prongs by first unscrewing the nozzle assembly from the injector to expose the prongs. Since the prongs are no longer confined by the ampule chamber wall, the prongs can expand outwardly and release the enlarged head when it is pulled away therefrom.
- Another aspect of the present invention includes a needleless injection device in which the housing can be formed in whole or in part of a durable plastic composition such as the aforementioned liquid crystal polymer, available under the trade name VECTRA ® .
- a durable plastic composition such as the aforementioned liquid crystal polymer, available under the trade name VECTRA ® .
- Such composition allows for weight reduction and helps to eliminate lubrication that might otherwise be utilized in the assembly and operation of metallic housings.
- Another aspect of the present invention includes a nozzle assembly that can be formed of a strong material capable of withstanding high pressure and stress such as gamma stabilized high impact polycarbonate, polypropylene and any derivatives thereof, or any medical grade material or composite capable of withstanding the pressure and stress subjected by the injector during use.
- the nozzle and the plunger can be made of the same material, including stainless steel.
- the nozzle assembly comprises a main hollow cylindrical body terminating in a circular cone at one end and open at the opposite end, the inner wall of the body forming a cylindrical ampule chamber.
- the nozzle assembly includes external acme threading or any conventional fasteners to facilitate quick removal of or attachment to the injector.
- Grooves or any attachment means, such as cap mating surfaces for engaging the coupling device's quick release members described below can be formed around the outer side of the nozzle assembly to facilitate attachment of a medication filling device.
- a plunger having a pressure wall contoured to the cone is positioned to slide within the ampule chamber.
- An end of the plunger opposite the pressure wall has a connector that can be removably engaged with an end of a piston or ram or the like as described above.
- a stop member can be provided at the end of the nozzle assembly if desired to retain the plunger therein during the disconnection of the nozzle assembly from the injector. Alternatively, the stop member can be omitted entirely if used with the quick release connector described above.
- the coupling device for coupling a medication supply vial to a nozzle assembly of a needleless injection device or the like.
- the coupling device comprises a hollow main body having a first end and a second end opposite the first end.
- the main body is preferably cylindrical, but can be of any other configuration desired.
- a dividing wall having a first side and an opposite second side is positioned between the first and second ends. The first side is positioned closer to the first end than the second end, and the second side is positioned closer to the second end than the first end.
- the wall also has a throughhole.
- a hollow probe extends from the first side of the wall toward the first end, with its free end terminating within the main body such that it does not protrude beyond the first end. The probe is positioned to be in fluid communication through the throughhole.
- a medication supply vial connector is formed on the first end for connecting to a medication supply vial, which permits insertion of said vial but prevents removal of said vial therefrom.
- a nozzle connector is formed on the second end, which has at least one quick release member that grabs a portion of the nozzle assembly, where the connection is made by pushing the connector toward the nozzle assembly and disconnecting made by a sufficient pulling and/or twisting force.
- the probe punctures through a vial seal upon connection of the vial to the nozzle connector and provides a fluid communication through the throughhole.
- the coupling device is coupled to a needleless injector simply by pushing it toward the nozzle assembly and is removed by simply pulling and/or twisting the same off the injector. When the vial is pushed towards the probe, the probe punctures through the seal and provides a fluid communication from the vial through the throughhole formed on the wall.
- the coupling device further includes a stretchable diaphragm seal member positioned in abutting relationship with the second side of the dividing wall.
- the seal member can have a zero diameter opening generally in alignment with the throughhole, but preferably has an open aperture or hole. The zero diameter opening seals the throughhole until it is opened by stretching the seal member.
- the seal member abuts against the second side of the dividing wall to provide a liquid-tight seal between the nozzle assembly and the throughhole.
- a ring is preferably positioned in abutting relationship with the seal member. The configuration of the ring is complementary to the shape of the nozzle assembly to allow a precise alignment of the nozzle assembly to the coupling device.
- a protective cap is provided at the second end, which can be engaged with the ring and the quick release members to protect and close the second end. The cap has mating surfaces for engaging the quick release members.
- the vial connector comprises at least one flexible tooth extending toward the wall, wherein an end of the tooth engages a portion of the supply vial.
- the supply vial has means cooperating with the tooth to prevent removal thereof from the coupling device.
- the connector comprises a pair of flexible opposed teeth extending from the first end of the main body toward the first side of the dividing wall. The opposed teeth converge toward each other in the direction toward the dividing wall, where their free ends are configured to engage a portion of the supply vial to prevent the vial from being removed.
- the nozzle connector preferably has a plurality of quick release members, each extending substantially parallel with the main body.
- the quick release members are resilient to expand radially away from each other during insertion of the nozzle assembly or the cap and to return substantially to its original relaxed condition when fully inserted.
- Each release member has a radially inwardly projecting portion that cooperates with the nozzle assembly for securement thereof.
- a stepped gas spring described above which outputs a substantially constant force above, having a first piston portion extending axially outwardly at one end of the sleeve and the second portion extending axially outwardly at the other end of the sleeve in the opposite direction.
- One of the first and second piston portions includes a piston gripping means, preferably a circular groove or channel or the like formed around the one piston portion. The circular groove is preferably formed around near the free end of the second piston portion.
- the stepped gas spring further includes means for immobilizing the sleeve and for compressing the piston.
- the immobilizing and compressing means can be a needleless injector or a projectile launching device, which includes means for either pulling the second piston portion or pushing the first piston portion.
- Another aspect of the present invention includes a projectile launching device for launching a projectile by a compressed air.
- the launching device comprises an outer hollow cylinder having a side wall and a closed end wall with an air discharging port.
- a barrel having a bore is connected to the cylinder, with the bore communicating with the port.
- a firing piston having a closed wall member is positioned within the hollow cylinder for movement therein.
- the closed end wall, the closed wall member and the side wall define a gas spring chamber.
- a stepped gas spring is connected to the firing piston for rapidly moving the firing piston toward the closed end wall to compress air within the firing chamber.
- the launching device includes a mechanism for forcing the firing piston away from the closed end wall and a trigger mechanism for maintaining the firing piston away from the closed end wall.
- the second piston portion is connected to the firing piston.
- the first piston portion extends axially outwardly at one end of the sleeve and the second piston portion extends axially outwardly at the other end of the sleeve in the opposite direction.
- a trigger engaging notch is formed on the second piston portion to engage the trigger mechanism and maintain the piston in an energized compressed state.
- An end of the first piston portion is connected to the firing piston.
- Fig. 1 is a cross-sectional view of the needleless injector according to the present invention, with the actuating mechanism in the closed condition and the gas spring in its neutral condition.
- Fig. 2 is a cross-sectional view of the needleless injector of Fig. 1, with the actuating mechanism in the extended condition and the gas spring in its energized condition.
- Fig. 3 is a cross-sectional view of the needleless injector of Fig. 2, but with the gas spring in its neutral condition.
- Fig. 4 is a cross-sectional view of another embodiment of a needleless injector according to the present invention, with the actuating mechanism in the extended condition and the gas spring in its neutral condition.
- Fig. 5 is a cross-sectional view similar to Fig. 4, with the actuating mechanism in the closed condition and the gas spring in its energized condition.
- Fig. 6 is a cross-sectional view similar to Fig. 5, but with the actuating mechanism in the open condition and the gas spring in its energized state, ready for firing.
- Fig. 7 is an enlarged cross-sectional view of the energy mechanism according to the present invention.
- Figs. 8 and 9 illustrate alternate embodiments of the piston for use in the needleless injector and the air gun according to the present invention.
- Fig. 10 is a cross-sectional view of another embodiment of a nozzle assembly according to the present invention.
- Fig. 11 is a cross-sectional view of yet another embodiment of a nozzle assembly according to the present invention.
- Fig. 12A illustrates a plunger having a quick connector for releasably mounting to the end of a piston in a gas spring according to the present invention, with a portion thereof illustrating a broken view taken along line 12A-12A of Fig. 12C.
- Fig. 12B is a cross-sectional view taken along line 12B-12B of Fig. 12A.
- Fig. 12C is an end view of the plunger illustrated in Fig. 12A.
- Fig. 12D is a portion of a piston extending from the gas piston, with an enlarged end.
- Fig. 13 is a schematic representative graph illustrating pressure-time curves for the gas spring injector relative to a coil spring injector.
- Fig. 14 is an exploded perspective view of the coupling device according to the present invention.
- Fig. 15 is an end view of the coupling device of Fig. 14.
- Fig. 16 is the other end view of the coupling device of Fig. 14.
- Fig. 16A is another embodiment of the coupling device illustrated in Fig. 14.
- Fig. 17 is a cross sectional view of the coupling device of Fig. 14 coupled to a medical supply vial and a needleless injector.
- Fig. 18 is a cross-sectional view of an air gun, with the firing mechanism in the armed and ready for firing condition.
- Fig. 19 is a cross-sectional view similar to Fig. 18, with the firing mechanism in the unarmed, fired condition.
- FIGs. 1-19 illustrate different embodiments of the present invention.
- a needleless injection device 10 according to the present invention, referring to Figs. 1-6, comprises a nozzle assembly 20, an energy source or mechanism 40 for forcing medication out of the nozzle assembly, and an actuating mechanism 90, 90A and a trigger assembly 100 for activating and triggering the energy mechanism 40. These components are operatively contained in a housing 200, 200A as shown.
- the nozzle assembly 20 includes a nozzle member 22 having an orifice 24, preferably having a diameter about 0.07 - 0.4 mm, preferably of about 0.165 mm (0.0065 inches) or any other suitable diameter that would produce a uniform jet stream under a given desired pressure range and depth of injection.
- the orifice can be formed of a synthetic gem material, such as a synthetic ruby or sapphire, as disclosed in the '728 patent. It should be noted that the orifice means any type of opening, including a straight, convergent, divergent, convergent-divergent, etc.
- the nozzle assembly 20 can be threadably connected to the housing 200 or the actuating mechanism 90A such that it can be readily attached and detached, as better shown in Figs. 10 and 11.
- Alternatively, other known structures for mounting or attaching two components can be utilized as well to detachably mate the nozzle assembly 20 to the housing 200.
- the needleless injector 10 can be reused with various nozzle assemblies 20 that may contain different medications to allow for injection of various medications or medications of different doses either together or at different times.
- the nozzle assembly 20 can be prefilled with medication and disposed of after each use.
- a medication filling device such as a coupling device 120 according to the present invention and the adapter described in the '113 patent, the disclosure of which is incorporated herein by reference, or any other coupling device can be used to fill the ampule chamber with medication.
- the nozzle assembly 20, 20A shown in Figs. 1-6 and Fig. 10 includes a cylindrical ampule chamber 26 terminating in a right circular cone 28.
- the nozzle assembly 20B shown in Fig. 11 also includes a cylindrical ampule chamber 26, but terminates in a convex cone 28' where the wall converges with a convex curvature.
- a plunger 30 having a pressure wall contoured to the cone 28, 28' is positioned to slide within the ampule chamber 26.
- the plunger 30, 30A, 30B can include a sealing means such as an O-ring(s) or the like (not shown) formed around its outer periphery to provide a seal or the plunger itself can be a seal, as described, for instance in the '830 patent, the disclosure of which is incorporated herein by reference.
- the plunger can also include additional sealing means at spaced intervals to provide a better seal.
- the plunger 30 is connected to a ram 32 which is connected to the energy mechanism 40.
- the ram 32 can be integrally formed with an energy mechanism if desired.
- the plunger includes a connector shaft 31 having a ball end 31a.
- the ram 32 is connected to or integrally formed with an inertia mass 36 which in turn is connected to or integrally formed with the piston 58 of the gas spring 50.
- the inertia mass can be removably connected to the piston and the ram such that the mass can be adjusted to accommodate different types of injections, taking into consideration, for instance, the viscosity of the medication, the initial pressure build up desired, the strength of the gas spring 50 and the depth of injection penetration, etc.
- the piston 58 can also be directly connected with the plunger if desired. If the nozzle assembly and the plunger are not disposable, they can be made of any durable inert material such as stainless steel. According to another aspect of the present invention, Figs.
- disposable nozzle assembly 20A, 20B including the plunger that can be made from a strong material capable of withstanding high pressure and stress such as gamma stabilized high impact polycarbonate, polypropylene and any derivatives thereof, or any medical grade material, including glass or composite thereof, compatible with the medication product and able to withstand the pressure and stress subjected by the injector.
- the nozzle assembly 20A, 20B preferably includes a conventional acme threading 25 to facilitate faster removable or attachment to the housing 220 or the actuating mechanism 90A.
- Grooves 27 or any attachment means can be formed around the outer side of the nozzle assembly 20A, 2OB to facilitate the attachment of, for example, the present coupling device 120 or an adapter such as the one described in the '113 patent.
- a stop member 29 can be provided within the end of the nozzle assembly 20A, 2OB as shown in Figs. 10 and 11 to retain the plunger therein when disconnecting the nozzle assembly from the housing 200, 200A or the actuation mechanism 90A.
- the stop member can engage the ends of the prongs 30a, for example.
- the stop member is dimensioned to enable the ram 32 or the first piston portion 58a to move into the ampule chamber 26.
- any conventional quick disconnecting means can be used which allows disconnection thereof by unscrewing the nozzle assembly from the injector and/or pulling the nozzle assembly with a force sufficiently greater than the force required to move the plunger during use so that the plunger can only be disconnected from the piston by a deliberate manual action.
- the plunger 30C is substantially similar to the plunger 30, 30A and 30b, except that it has a resilient snap fitting connector 30a for removably connecting directly to the end of the first piston portion 58a.
- the connector 30a has at least one prong 30b, four being preferably and illustrated, each prong extending substantially parallel with the main body portion 30c.
- a lateral extension or tab 30d is formed, which extends radially inwardly toward the central axis thereof.
- the first piston portion 58a illustrated in Fig. 12D has an enlarged free end 58c that engages with the prong to provide a desired length of free travel or lost motion.
- the first piston portion can also have an annular channel of a predetermined width adjacent an enlarged head, as disclosed in the '830 patent.
- the prongs 30b can be made of resilient material, which upon being first attached to the enlarged free end or head 58c, expand laterally outwardly to permit the free end to pass through the tabs 30d and return to its original configuration shown in Fig. 12A, once the enlarged end 58c passes the tabs.
- the thickness or depth D of the enlarged head is less than the width W provided between an end wall 30e and the tabs to allow free play or gap defined by W - D, a gap of at least about 3.5mm being preferred.
- the enlarged end 58c is dimensioned to freely move relative to the plunger 30C within the gap, but prevented from being disengaged from the plunger during use.
- the tabs 30d engage the shoulder portion 58d of the piston 58, and the entire plunger, including the prongs, is confined within the ampule chamber.
- the prongs are dimensioned to slide inside the ampule chamber the inner wall of the chamber confines the prongs from moving laterally outwardly, thus maintaining the piston engaged to the plunger during use.
- the plunger 30C is disconnected from the enlarged end 58c by first unscrewing the nozzle assembly from the injector to expose the prongs. Since the prongs are no longer confined by the ampule chamber wall, the prongs can expand laterally outwardly and release the enlarged end when it is pulled away therefrom. If the plunger 30C is used the nozzle assembly 20, 20A, no stop member 29 or the like should be provided in the ampule chamber 26 to allow insertion and removal of the plunger.
- the spacing formed between the end wall 3Of of the main body portion 30c and the end wall 30g of the pressure wall member can be provided to accommodate a sealing means such as an O-ring, as shown in the '830 patent.
- the energy mechanism 40 includes a gas spring 50 for driving the plunger 30 so that the front wall thereof will force the medication out of the nozzle assembly ampule chamber 26.
- the gas spring 50 is positioned generally collinear with and spaced from the nozzle assembly 20.
- the gas spring unit 50 includes a sleeve 52 with open ends, preferably cylindrically shaped or shape configured to the shape of the housing 200, 200A of the injector.
- the sleeve 52 is fixably or removably positioned within a cylindrical cavity 210 formed inside the housing.
- the open ends are closed using two end plugs 54 and 56, each having a central aperture in alignment with the longitudinal axis of the sleeve 52.
- the end plugs 54, 56 are fixedly disposed so that they do not move relative to the sleeve 52 through conventional retaining means.
- the end plugs are cylindrical, corresponding to the cylindrical inner periphery of the sleeve 52.
- the end plugs are positioned inside the sleeve 52 adjacent its open ends. Both of the open ends of the sleeve 52 are crimped, as shown in Fig. 7, toward the axis thereof to form circular stopping edges 55 and 57, respectively. These stopping edges prevent the end plugs from moving away from each other relative to the sleeve 52.
- abutment rolls 58 and 59 can be formed adjacent to the inner sides of the plugs, for instance by radially creasing the sleeve 52, to prevent the end plugs from moving toward each other.
- the stopping edges 55, 57 and the abutment rolls 58, 59 prevent the end plugs from moving in the axial direction relative to the sleeve 52. It is understood that other stopping or retaining means can also used to retain the end plugs 38 and 40 in position, such as screws, pins, adhesives, etc.
- a stepped piston 58 is coaxially positioned relative to the sleeve and the end plugs such that the piston can slidingly move relative to the end plugs.
- the stepped piston 58 has a first portion 58a having a diameter DI and a second portion 58b having a diameter D2, as shown in Fig. 7.
- the diameter DI is at least twice the diameter D2.
- the aperture formed in the end plug 54 needs to be larger to accommodate the first piston portion 58a.
- the gas spring chamber 51 defined by the sleeve 52 and the end plugs 54, 56, is pressurized preferably using nitrogen or other inert gas having a relatively large molecule. Use of a gas with a relatively large molecule minimizes gas escape.
- each of the end plugs is provided with a first seal, such as an O-ring 62, 63, positioned around a groove formed on the outer periphery of the end plug 54, 56.
- a first seal such as an O-ring 62, 63
- the diameter of the O-ring is preferably slightly larger than the depth of each groove formed on the end plugs so that the O-ring is pressed tightly to sufficiently seal against the inner periphery of the sleeve 52.
- a second seal 64 comprising a disk 64a formed of a soft elastic material and a relatively rigid washer 64b is collinearly and contiguously positioned against the inner face of the end plug 54.
- the abutment roll 58 is positioned adjacent to the second seal to maintain the second seal in place.
- a second seal 66 comprising a disk 66a formed of a soft elastic material and a relatively rigid retainer 66b can be collinearly and contiguously positioned within a cylindrical cavity formed within the end plug 56.
- the retainer 66b is positioned to immobilize the disk 66a.
- a washer similar to the washer 64b can be used to immobilize the disk 66a.
- any conventional or known sealing mechanism can be used, which is well within the ambit of one skilled in the art.
- a relatively highly pressurized gas spring requires seals to prevent gas from escaping through the piston 58. This may require a tight seal fitting which can create a mechanical friction, which in turn can slow the initial acceleration of the piston. Since the stepped piston 58 has to be capable of sliding relative to the second seals 64, 66, the seals should not be so tight as to prevent the piston 58 from moving. When compared to a coil spring, the gas spring has a slower initial acceleration due to this static friction. To compensate for this phenomenon, the present invention is provided with a lost motion connection mechanism between the ram 32 or the piston 58a and the plunger 30. As shown in Figs.
- a small gap 34 of preferably about at least 3.5mm is provided between an end of the plunger 30 and an end of the ram 32 or the first piston portion 58a when the piston is pulled away from the sleeve 52 to the ready for firing configuration.
- This free play movement or the lost motion connection compensates for the initial slower reaction by delaying the engagement of the ram 32 or the first piston portion 58a to the plunger 30.
- the piston is not acted upon until the piston 58 has moved by the distance of the gap 34, at which point the ram 32 and/or the piston 58 have accelerated to its maximum or are approaching its maximum. Accordingly, when the ram engages the plunger, it has built up sufficient momentum to create the initial pressure necessary to pierce through the skin.
- the gap 34 is adjustable as will be explained hereinbelow to vary the amount of the initial impact imparted on the plunger to generate desired peak pressure.
- the peak pressure can vary depending upon the viscosity of the medication, the injection penetration depth and other parameters which may affect the initial injection pressure output.
- a trigger extension or gas spring coupling mechanism 70 having a trigger engaging notch 72 is attached to the end of the second portion 58b, for example, by a threaded engagement.
- the end of the first piston portion 58a is connected to the inertia mass 36.
- the inertia mass can be omitted if the weight of the first piston portion is sufficient to generate desired initial momentum that would produce the level of the initial pressure build-up (at c as schematically shown in Fig. 13), required to penetrate the medication to the injection depth.
- the gas spring chamber 51 is relatively highly pressurized to a selective degree.
- the pressure in the gas spring chamber is inverse proportional to the volume. That is, if the volume of the gas spring chamber is decreased, then the pressure will proportionally increase by the reduction of the volume and vice-versa. Accordingly, when the piston 58 is either pulled or pushed in the direction of R relative to the sleeve 52, the piston portion 58a having a larger diameter than the piston portion 58b will occupy the space inside the gas spring chamber 51, consequently reducing the volume thereof. This causes the pressure in the gas spring chamber 51 to rise. If the piston is released, it will accelerate in the direction that will reduce the pressure in the gas spring chamber. Thus, the force exerted against the plunger 30 will be substantially equal to the force created by the increase of the pressure, minus the loss due to friction and heat.
- junction 58c between the piston portions 58a and 58b can be stepped as shown in Fig. 7, or alternatively, it can be beveled as shown in Fig. 8, or curved as shown in Fig. 9.
- the differences among these configurations are negligible for the present purpose as the volume differences between these embodiments are relatively small.
- the energy device actuating mechanism 90 includes a trigger assembly 100 and actuating means for moving the trigger extension 70 along the directions L and R.
- This actuating mechanism 90 is tubular, with substantially cylindrical inner threading formed on the winding sleeve portion 92 thereof which threadably and coaxially engages with the counterpart outer threaded portion 220 formed on the housing 200.
- the threaded portion 220 is formed at its outer periphery along the longitudinal length thereof.
- the winding sleeve portion 92 has cooperating threads 94 formed on the inner periphery along a portion of the longitudinal length thereof.
- the trigger assembly 100 comprises a latch housing sleeve 102 fixedly attached to the actuating mechanism 90.
- the latch housing sleeve 102 has a throughbore dimensioned to allow passage of the trigger extension 70.
- the sleeve 102 further has a plurality of sidewall openings 104 dimensioned to allow passage of balls or ball bearings 106.
- a tubular button 108 having one open end and a closed end is telescopingly positioned with the sleeve 102 as shown.
- the button 108 has a circumferential or annular groove 110 formed on the inner wall 109 thereof to allow portions of the balls 106 to engage the groove 110 when the trigger mechanism 100 is in the fired position as shown in Fig.
- the balls 106 are positioned so that it is substantially flush with the inner side wall surface 103 of the sleeve 102 as shown in Fig. 3 to allow the trigger extension 70 to pass through the sleeve 102.
- a latch ball retaining cup 112 is telescopingly positioned within the button 108 as shown in Fig 3.
- a compression spring 114 is positioned between the cup 112 and the button 108 as shown in the Figs. 1-3 to bias the button 108 and the cup 112 away from each other in the axial direction.
- the housing 200, 200A and the actuating mechanism 90, 90A can be made of any durable material, including stainless steel, and plastics and any composite material, including plastic or composite material, with or without additives such as binders, fillers, fibers, carbon and the like, etc., well known to one of ordinary skill in the art.
- the weight of the injector can be reduced by using a lighter plastic material, rendering the device more user friendly since a lighter device can be more easily handled.
- the lighter weight will also allow persons to carry such injectors during daily travels and thereby allow for use wherever the person should need an injection.
- the plastic composition is a liquid crystal polymer available from Hoechst Celanese under the trade name VECTRA ® , in particular VECTRA ® A430 and A435.
- compositions provide a high strength to weight ratio and offer the added advantage in that it can be processed relatively easily on both injection molding and extrusion equipment.
- these compositions include PTFE fluorocarbon or fluoropolymer for improved or enhanced lubricity to eliminate use of lubrication that would otherwise be used with metallic structures for assembly and/or operation.
- the sleeve portion 92 of the actuating mechanism 90 is rotated relative to the housing 200 from the condition shown in Fig. 3 to the closed condition shown in Fig. 1 to cause the trigger extension to engage the balls 106.
- the trigger mechanism moves toward the trigger extension 70, it first pushes the latch retaining cup 112 outwardly, causing the balls to engage the trigger engaging notch 72 formed on the trigger extension 70 as shown in Figs. 1 and 2. Since the button is free to move outwardly, the spring 114 forces the button outwardly.
- the balls 106 are locked in the position between the notch 72 and the inner side wall 109 of the button as shown in Figs. 1 and 2, locking the piston to the trigger.
- the trigger extension 70 is locked to the actuating mechanism such that rotation of the same to displace in the other direction (R) causes the piston 58 to move in the same direction R to further compress the gas spring chamber 51.
- the plunger simultaneously draws medication (see below concerning the coupling device 120 for coupling a medication supply vial to a nozzle assembly of a needleless injector) into the ampule chamber 26.
- the injector is held upright and a small dose of the medication is first drawn into the chamber 26.
- the medication is fully ejected out of the chamber 26 and into the vial or the connector can be disconnected to eject the same into a separate container for disposal, depending upon the application or any medication restriction. Any air contained in the chamber 26 is purged into the vial or the ambient. Then, the desired dosage of the medication is withdrawn into the chamber 26 without any air trapped in the chamber.
- the gap 34 can now be made narrower as desired without moving the plunger by rotating the sleeve portion 92 in the appropriate direction. It should be noted that the plunger cannot move until the gap is first closed or fully at its maximum. The injector is ready for firing.
- Fig. 3 shows the condition of the injector after it has been fired.
- the embodiment shown in Figs. 4-6 operates substantially similarly as described above with respect to Figs. 1-3. However, whereas the piston 58 is pulled to energize the piston in the embodiment of Figs. 1-3, the piston is pushed in the embodiment shown in Figs. 4- 6. Whereas the nozzle assembly 20 is connected to the housing 200 in the embodiment shown in Figs. 1-3, the nozzle assembly 20 is connected to the actuating mechanism 90A in the embodiment shown in Figs. 4-6. Specifically, in the embodiment shown in Figs. 4-6, the energy device actuating mechanism 90A is threadably connected to the housing 200A that holds the gas spring sleeve 52.
- the trigger assembly 100 is connected or contained in the housing 200A, but is not movable relative to the housing as in the embodiment shown in Figs. 1-3.
- the actuating mechanism 90A is tubular, with substantially cylindrical inner threading formed on the winding sleeve portion 92A thereof which threadably and coaxially engages the counterpart outer threaded portion 22OA formed on the housing 200A.
- the threaded portion 22OA is formed at its outer periphery along the longitudinal length thereof.
- the winding sleeve portion 92A has cooperating threads 94A formed on the inner periphery along a portion of the longitudinal length thereof.
- the sleeve portion 92A is first rotated relative to the housing 200A toward the trigger assembly 100 from the state shown in Fig. 4. This causes the plunger 30 to abut against the cone 28 of the nozzle assembly ampule chamber 26 and push the first piston portion 58a into the gas spring chamber 51, moving the second piston portion toward the trigger assembly until the notch 72 engages the balls 106, locking the gas spring in the fully energized state as shown in Fig. 5.
- the sleeve portion 92A is now rotated in the other direction to draw the nozzle assembly away from the plunger and draw medication into the ampule chamber 26 into the state shown in Fig. 6.
- the injector is held upright and a small dose of the medication is first drawn into the chamber 26 by rotating the sleeve portion in the direction that will move the plunger away from the orifice. This creates a vacuum in the ampule chamber, causing the medication to fill the ampule chamber. Then, still maintaining the upright position, the medication is fully ejected out of the chamber 26 and into the vial or the connector can be disconnected to eject the same into a separate container for disposal, depending upon the application or any medical restriction, by rotating the sleeve portion 92A in the direction that will move the plunger toward the orifice. Any air contained in the chamber 26 is purged into the vial or the ambient.
- the desired dosage of the medication is withdrawn into the chamber 26 without any air trapped in the chamber.
- the gap 34 can now be made narrower as desired without moving the plunger by rotating the sleeve portion 92A in the appropriate direction.
- the button 108 is pressed inwardly, the groove 110 is positioned over the balls, releasing the trigger extension 72, causing the piston to accelerate in the direction that would purge the medication out of the ampule chamber 26.
- Fig. 4 shows the condition after the piston has been released or fired.
- the injection pressure is maintained with a substantially less pressure drop than a corresponding coil spring injector to allow a faster injection time.
- the stepped gas spring is not believed to be as efficient as a conventional gas spring which does not have a gas piston extending through both ends thereof, the stepped gas spring is superior to the coil spring as the injection pressure drop of the gas spring is less during the injection period than the coil spring.
- a 75lbs gas spring (approximate net output) can be formed with a gas spring chamber having a volume of 4698mm 3 , with an internal diameter of 13mm and length of 35.4mm is pressurized to 1,600 psi.
- a 3mm diameter second portion 58b occupies the chamber for a length of 35.4mm, occupying 250mm 3 when it is in a fully extended state (neutral position) .
- the approximate force constant can be calculated from the cross-sectional area working on the pressure.
- a 7mm diameter first portion 58a occupies the chamber for a stroke of 23mm, occupying 885mm 3
- the 3mm diameter second portion 58b occupies the chamber for a length of 12.4mm, occupying a volume of about 88mm 3 . Therefore, the volume of the chamber at full extension is about 4448mm 3 and at full compression is about 3725mm 3 .
- Fig. 13 illustrates schematic injection pressure-time curves comparing the present gas spring to a coil spring.
- A represents the gas spring curve and B represents the coil spring curve.
- the pressure at point d can be made about the same for both springs.
- the pressure at the end of the injection period for the gas spring is significantly higher than that of the coil spring. The gas spring can thus better sustain the initial pressure throughout its injection period, meaning less pressure loss.
- gas spring can use a weaker gas spring, i.e., have a lower initial injection pressure (at d) . That is, with the coil spring, the initial pressure at d needs to be at a higher level to compensate for the faster decrease in the pressure throughout the injection period to avoid a wet injection.
- a significant advantage of the gas spring injector is that it allows for a faster injection period for the same given dose as compared with the coil spring since there is a less loss of injection pressure for a given injection period.
- the pressure output does not significantly depend upon how much the piston 58 is pulled back with respect to the present injector shown in Figs. 1-3.
- the present invention can achieve a substantially uniform pressure throughout the injection period regardless of the dosage amount.
- even a small dosage injection which only requires a small withdrawal of the plunger 30 from the ampule chamber 26 and thus the piston 58, can produce substantially the same constant pressure output as for a larger dosage injection that requires a larger withdrawal of the piston.
- gas spring energization varies according to the dosage of the medication to be injected in the embodiment of Figs. 1-3, the energization remains constant regardless of the dosage in the embodiment of Figs. 4-6.
- the injector according to the present invention thus contemplates many different applications and uses.
- gas spring does not produce significant initial pressure fluctuations, which are inherent in the coil spring. Such fluctuations are the result of the "slinky” or “ping-pong” effect, longitudinal oscillation produced in the coil spring.
- gas spring may have a force constant of 75lbs can be replaced with a stronger or weaker force constant.
- the gas spring constant can be increased or decreased without altering the size of the gas spring. This can be accomplished by either changing the D1/D2 ratio or increasing or decreasing the pressure in the gas spring chamber, i.e., higher pressure results in a stronger gas spring and vice-versa.
- the ratio of the volume of the gas spring chamber and the volume of the piston occupied in the chamber when fully compressed be preferably about 4:1 and greater to maintain a minimum pressure drop.
- the strength of the gas spring can be changed to accommodate different types of injections such as intradermal and intramuscular injections, as well as subcutaneous (fat tissue) and fascia (which overlies muscle) injections, or oven through the muscle to the periosteum (bone surrounding tissue) .
- the diameter of the orifice can accordingly be changed to accommodate different types of injections.
- FIG. 14-17 Another aspect of the present invention is a coupling device or adapter 120, as shown in Figs. 14-17, for coupling a medication supply vial 122 to a nozzle assembly 20 of any needleless injector, including a coil spring operated injectors as shown for example in the '830, '543 and '818 patents, the disclosures of which are incorporated herein by reference, as well as the present gas spring injector and gas operated injectors described above.
- the medication supply vial 122 herein means any container for holding medication, regardless of the size, shape or form of the container.
- the vial could be as shown herein, as shown in the '878, '483 and '113 patents, as well as an ampule, TUBEX ® or any cylindrical container.
- the coupling device 120 comprises a generally elongated hollow cylindrical main body 124 having a first end 126 and a second end 128 opposite the first end 126. Although a cylindrical body is shown, any other body configuration can be used to accommodate various types of nozzle assembly and supply vial configurations.
- a dividing wall 130 having a first side 130A and an opposite second side 130B is positioned between the first end 126 and the second end 128.
- the first side 130A is positioned closer to the first end 126 than the second end 128, and the second side 130B is positioned closer to the second end 128 than the first end 126.
- a central hole 130C is formed through the dividing wall 130, which is generally collinearly aligned with a sharp-tipped hollow probe 132 extending therefrom between the first side 130A and the first end 126 to allow fluid from the vial to communicate through the wall 130.
- the probe 132 extends axially from the first side 130A toward the first end 126, but terminates within the main body such that it does not protrude beyond the first end 126 to prevent accidental sticking.
- the first end 126 has a medication supply vial connector 140 to permit connection with the supply vial 122, but prevent removal thereof once connected.
- the connector 140 comprises vial holders having a pair of flexible resilient teeth 142.
- Each tooth 142 is preferably tapered and defines a vial engaging free end 144.
- the teeth 142 are positioned diametrically opposite each other and extend inwardly and convergingly toward each other toward the wall 130.
- the ends 144 engage a neck portion 122A of the vial 122 which is preferably provided with means 121 cooperating with the teeth to prevent removal of thereof from the coupling device.
- the neck portion 122A could have a groove or a recess for engaging the ends 144 or could have a neck engaging sleeve 121 provided with an annular groove 123 as illustrated in Fig. 14.
- the vial could have an enlarged head followed by a narrower neck portion, as shown in the '878 patent. Any other alternate means that permits the vial to be inserted but make removal difficult can be used, i.e. , one way connection.
- the leading end (neck portion 122A) of the vial 122 forces the teeth 142 to spread apart. Once the neck portion or the head portion is inserted beyond or adjacent the free ends 144, the teeth 142 spring back to its original configuration, either engaging the recess 123 or the smaller neck portion 122A.
- the converging and biasing configuration of the teeth enables the recess 123 or the larger head to be abutted thereagainst to prevent the supply vial 122 from being removed in the opposite direction.
- the probe 132 punctures the seal thereof to provide a fluid communication through the passageway 132A formed therein.
- the second end 128 has a nozzle connector 150 having quick release members 152, 152' that automatically grab portions of the nozzle assembly 20 when the connector 150 is merely pushed into the nozzle assembly 20. Removal thereof is performed by pulling and/or twisting action.
- each member 152' is substantially similar to the member 152 shown in Figs.
- the member 152' is preferably slightly wider than the member 152 and has a slot 153 forming a pair of adjacent submembers 152", each of which can flex independently of the other.
- the release members 152, 152' extend substantially parallel with the longitudinal direction of main body as shown in Figs. 14, 16A.
- the quick release members 152, 152' are resilient to enable them to expand away from each other during insertion of the nozzle assembly and to return substantially to its original relaxed position when the same has been connected. However, it is preferable for the quick release members 152, 152' to be spread apart slightly when the nozzle assembly is connected to maintain a gripping force acting against the nozzle assembly, inwardly toward its neutral relaxed position.
- Each release member 152, 152' has a radially inwardly projecting portion or tab 152A that cooperates with the nozzle assembly 20 for securement thereof.
- the nozzle assembly can be formed with four complementary surfaces, recesses or notches, as shown for example by reference numeral 27 in Figs. 12 and 13, which can be used with wither two or four quick release members, to allow the projecting portion 152A to occupy the space therein and enable the coupling device to be securely attached to the nozzle assembly.
- the coupling device further includes a stretchable diaphragm seal member 160 positioned in abutting relationship with the second side 13OB of the dividing wall 130.
- the seal member 160 can have a zero diameter hole generally in alignment with the central opening. The zero diameter hole is formed by puncturing the seal member after it is first stretched, as described in the '113 patent, the disclosure of which is incorporated herein by reference.
- the seal member preferably has an open hole.
- the second side 130B of the dividing wall 130 is provided with a circumferential groove 130C.
- One side of the seal member 160 has a complementary circumferential ring portion 162 seated in the groove 130C.
- a ring 170 is positioned in an abutting relationship with the seal member, with the ring frictionally engaged to the inner wall of the main body 124 to retain the seal member 160 in an abutting relationship to the wall 130.
- the configuration of the inner periphery 172 of the ring 170 is complementary to the outer contour of the nozzle assembly to allow a precise alignment of the nozzle assembly to the coupling device.
- a protective cap 180 is preferably connected to the coupling device, in engagement with the ring 170 and the seal member 160 to protect and close the second end 128.
- the cap 180 can have four complementary mating surfaces or recesses 182 which is substantially similar to the recesses 27 formed on the nozzle assembly to accommodate either the four or two quick release members.
- the recesses 182 receive the tabs 152 to securely hold the main body 124 to the cap 180.
- the main body 124 including the medication supply vial connector 140 and the nozzle connector 150, and the ring 170 can be formed of a sterilized, non- toxic, any medical grade plastic composition such as polysulfone, polycarbonate resin, MOBAY MARKOLON 2658, GE LEXAN GR1310 or equivalents or any medical grade composition compatible with the medication.
- the seal member 160 is preferably formed of natural or synthetic rubber or the like.
- the connecting member can be packaged with the cap 180 connected in place or separately provided.
- the cap 180 is first disconnected from the main body 124 if the cap came connected.
- a medication supply vial 122 is then connected to the other end of the main body 140. Once the vial is inserted, it cannot be removed without a substantial force.
- the vial can be first coupled to the main body, and then the main body with the vial can be coupled to the nozzle assembly after the cap is removed.
- the hole in the seal member 160 is aligned with the orifice 24 formed in the nozzle assembly. In operation, the vial and the injection device is kept substantially at an upright stance to permit any air in the ampule chamber to escape through the orifice.
- the coupling device is disconnected from the injector and the cap is attached to close the opening formed in the seal member 160.
- the connecting device including the vial connected thereto can be saved for later use or discarded immediately if the medication instruction so indicates. In any event, the connecting device along with the vial is discarded as a unit when the vial becomes empty.
- the coupling device provides a relatively low cost, disposable means of mating the medication supply vial to the injection orifice.
- Another aspect of the present invention is an air gun or a device for launching a projectile by rapidly compressing air using the above described stepped gas spring. It is desirable to produce a uniform pressure at the compression chamber where the compressed gas propels the pellet through the barrel.
- the flow of hot, compressed air produced by non-uniform acceleration appears to likely deform the pellet and thereby impair its accuracy.
- a problem known as "piston bounce,” similar to the "slinky” effect described above, is common in air guns or spring operated guns. This problem is thought to have a detrimental effect on the accuracy. This bounce is caused by the air trapped between the piston crown and the front end wall of the outer cylinder at the end of the piston firing stroke.
- the gas spring according to the present invention produces a substantially uniform output pressure, which in turn can uniformly apply compressive force to the firing chamber.
- the piston-bounce is eliminated since the trapped air in the firing chamber at that instance will unlikely be greater that the constant spring force of about 150 to 200 lbs.
- the greater details of an exemplary embodiment of an air gun incorporating the present gas spring is illustrated in Figs. 18 and 19.
- the illustrated air gun comprises a barrel 300 in front of a firing mechanism 310 mounted to a stock 303.
- the firing mechanism according to the present invention comprises an outer hollow cylinder 320, a hollow piston 330, and a gas spring 50'.
- the outer hollow cylinder 320 has a front end wall 322 with a discharge port 324 and a cylindrical side wall 326 fixedly attached to a receiver 329 or the like, within which the hollow piston 330 slides.
- the hollow piston 330 has a cylindrical piston wall 332 with a lug 334 extending from the outer side thereof as shown in Figs. 18 and 19.
- the side wall 326 is provided with a longitudinal slot 328 through which the lug extends outwardly and moves in the longitudinal direction within the slot.
- One end of the side wall 332 has a closed end piston wall 336 while the opposite end is open.
- the outer side of the piston wall 332 has at least one O-ring seal 338 or the like.
- a firing chamber 340 is defined by the front end wall 322, the closed end wall 336 and the side wall 326, within which the air trapped therein is compressed when fired.
- the hollow piston can also have a soft lip ring seal as disclosed in the '686 patent.
- the gas spring 50' is substantially similar to the one shown in Fig. 7.
- the hollow piston 330 is fixably connected to the free end of the larger piston portion 58a' such that the piston 58' moves in unison with the hollow piston 330.
- the gas spring can be pressurized between 1500 - 2500 psi to produce about 150-200 lbs gas spring constant.
- Other pressures either greater or lower can be also used depending upon its application, i.e., propelling a projectile at a higher speed requires a greater pressure, and vice-versa.
- the barrel 300 is pivotable about a pivot pin 302 or the like to enable opening of a barrel breach 304.
- the barrel is opened by pivoting the barrel 300 relative to the stock 301 in the direction shown by the arrow 308. This allows access to the breach for insertion of a projectile or pellet 306 and for cleaning the barrel.
- the breach has an O-ring seal 305 or the like to provide an air tight communication between the firing chamber 340 and the bore 301 of the barrel.
- the barrel 300 is operatively linked to a cocking lever mechanism 310 such that when the breach is opened by pivoting the barrel in the direction shown by the arrow 308, the lever mechanism 310 moves in the direction shown by the arrow 314 to force the hollow piston 330 to the condition shown in Fig. 18.
- an end 312 of the lever mechanism abuts against the lug 334 until a trigger mechanism 350 engages the notch 72' formed on an end of the smaller piston portion 58b' .
- a stop 360 is formed on or connected to the receiver 329 so that it is adjacent to and adjoining the lip 57' of the gas spring 50' to prevent the gas spring from moving rearward during the cocking step.
- the trigger mechanism 350 maintains the gas spring locked in the condition shown in Fig. 18 until fired.
- the cocking mechanism for the present air gun can be a separate lever. Moreover, even a cocking mechanism similar to the actuating mechanism 90 shown in the present injector can be used to pull the hollow piston 330 rearwardly away from the front end wall 322. This enables adjustable power settings.
- the larger piston portion 58a' is forced into the gas spring chamber 51'.
- the gas spring chamber 51' is further pressurized.
- the piston 58 and the hollow piston 330 rapidly accelerate toward the front end wall 322 under the force of the gas spring. Air in the firing chamber 340 is increasingly compressed until it exceeds a threshold at which the pellet is propelled out of the breach and through the barrel.
- the present injector and the air gun have been exemplified using a stepped gas spring where the gas spring piston 58, 58' is movably positioned and the sleeve 52, 52' fixably held
- the present invention can also be contemplated with the stepped gas spring piston 58, 58' fixedly positioned and the sleeve 52, 52' movably positioned.
- the plunger 30 of the injector can be operatively propelled by the sleeve, at the end where the smaller piston portion 58b extends through the sleeve 52.
- a cylindrical driving sleeve (not shown) can be coaxially positioned with the piston so that the driving sleeve propels the plunger 30.
- the gas spring 50' can be reversely positioned such that the hollow piston 330 is driven by the sleeve 52' at the end where the smaller piston portion 58b' extends through the sleeve. This can be accomplished, for instance, by connecting the open end portion of the hollow piston 330 to the end of the sleeve where the smaller piston portion 58b' extends through.
- any non-stepped gas spring can be used with the present needleless injector and the air gun.
- Gas springs similar to the ones taught by the Taylor et al. patents can be incorporated in the present injector, as well as any other conventional gas springs (non-stepped which does not have a piston extending through both ends) such as the ones produced by INDUSTRIAL GAS SPRINGS LTD. , who also manufactures a stepped gas spring.
- the injector can utilize a gas spring having only the first piston portion 58a, with the other end completely sealed.
- the sleeve 52 can be stationarily held, with the first piston end connected to the plunger.
- the actuating mechanism can be connected as shown in Figs. 4-6 to push the piston into the gas piston chamber.
- the trigger mechanism can be situated to engage the first piston portion between the sleeve and the end of the piston.
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69627474T DE69627474D1 (en) | 1995-01-09 | 1996-01-11 | MEDICAL INJECTION SYSTEM WITH A GAS SPRING |
JP52172796A JPH10512165A (en) | 1995-01-09 | 1996-01-11 | Medical infusion system with gas spring |
AT96902588T ATE237380T1 (en) | 1995-01-09 | 1996-01-11 | MEDICAL INJECTION SYSTEM WITH A GAS SPRING |
AU46935/96A AU4693596A (en) | 1995-01-09 | 1996-01-11 | Medical injection system comprising a gas spring |
EP96902588A EP0802809B1 (en) | 1995-01-09 | 1996-01-11 | Medical injection system comprising a gas spring |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/369,812 US5599302A (en) | 1995-01-09 | 1995-01-09 | Medical injection system and method, gas spring thereof and launching device using gas spring |
US369,812 | 1995-01-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1996021482A2 true WO1996021482A2 (en) | 1996-07-18 |
WO1996021482A3 WO1996021482A3 (en) | 1996-09-12 |
Family
ID=23457035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/000086 WO1996021482A2 (en) | 1995-01-09 | 1996-01-11 | Medical injection system comprising a gas spring |
Country Status (8)
Country | Link |
---|---|
US (4) | US5599302A (en) |
EP (1) | EP0802809B1 (en) |
JP (1) | JPH10512165A (en) |
AT (1) | ATE237380T1 (en) |
AU (1) | AU4693596A (en) |
DE (1) | DE69627474D1 (en) |
TW (1) | TW387814B (en) |
WO (1) | WO1996021482A2 (en) |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5769138A (en) * | 1996-04-01 | 1998-06-23 | Medi-Ject Corporation | Nozzle and adapter for loading medicament into an injector |
JP2000107289A (en) * | 1998-10-05 | 2000-04-18 | Showa Yakuhin Kako Kk | Cartridge type dental syringe unit |
EP1100566A1 (en) * | 1998-07-27 | 2001-05-23 | Medi-Ject Corporation | Loading mechanism for medical injector assembly |
WO2007131025A1 (en) * | 2006-05-03 | 2007-11-15 | Antares Pharma, Inc. | Injector with adjustable dosing |
EP2023981A1 (en) * | 2006-06-07 | 2009-02-18 | Acushot Inc. | Charging mechanism for a needle-free injector |
JP2009056339A (en) * | 1998-07-27 | 2009-03-19 | Antares Pharma Inc | Jet injector |
WO2009111794A1 (en) * | 2008-03-07 | 2009-09-11 | Pharmajet, Inc. | Intradermal injector and uses thereof |
US8052645B2 (en) | 2008-07-23 | 2011-11-08 | Avant Medical Corp. | System and method for an injection using a syringe needle |
US8177749B2 (en) | 2008-05-20 | 2012-05-15 | Avant Medical Corp. | Cassette for a hidden injection needle |
WO2012085579A3 (en) * | 2010-12-22 | 2012-08-16 | Owen Mumford Limited | Autoinjectors |
US8764753B2 (en) | 2007-02-14 | 2014-07-01 | Depuy Mitek Inc. | Implement for orientating a tool, particularly useful in surgical tools for harvesting and implanting bone plugs to repair damaged bone tissue |
US9629959B2 (en) | 2005-01-24 | 2017-04-25 | Antares Pharma, Inc. | Prefilled syringe jet injector |
US9707354B2 (en) | 2013-03-11 | 2017-07-18 | Antares Pharma, Inc. | Multiple dosage injector with rack and pinion dosage system |
US9737670B2 (en) | 2002-02-11 | 2017-08-22 | Antares Pharma, Inc. | Intradermal injector |
US9744302B2 (en) | 2013-02-11 | 2017-08-29 | Antares Pharma, Inc. | Needle assisted jet injection device having reduced trigger force |
US9750881B2 (en) | 2009-03-20 | 2017-09-05 | Antares Pharma, Inc. | Hazardous agent injection system |
US9808582B2 (en) | 2006-05-03 | 2017-11-07 | Antares Pharma, Inc. | Two-stage reconstituting injector |
US9950125B2 (en) | 2012-04-06 | 2018-04-24 | Antares Pharma, Inc. | Needle assisted jet injection administration of testosterone compositions |
US9974904B2 (en) | 2008-05-20 | 2018-05-22 | Avant Medical Corp. | Autoinjector system |
US10092706B2 (en) | 2011-04-20 | 2018-10-09 | Amgen Inc. | Autoinjector apparatus |
US10092703B2 (en) | 2013-03-15 | 2018-10-09 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
US10279131B2 (en) | 2011-07-15 | 2019-05-07 | Antares Pharma, Inc. | Injection device with cammed RAM assembly |
US10357609B2 (en) | 2012-05-07 | 2019-07-23 | Antares Pharma, Inc. | Needle assisted jet injection device having reduced trigger force |
US10492990B2 (en) | 2013-03-15 | 2019-12-03 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
US10568809B2 (en) | 2011-07-15 | 2020-02-25 | Ferring B.V. | Liquid-transfer adapter beveled spike |
USD898908S1 (en) | 2012-04-20 | 2020-10-13 | Amgen Inc. | Pharmaceutical product cassette for an injection device |
US10894130B2 (en) | 2015-04-10 | 2021-01-19 | Daicel Corporation | Syringe |
Families Citing this family (598)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995003844A1 (en) * | 1993-07-31 | 1995-02-09 | Weston Medical Limited | Needle-less injector |
FR2718357B1 (en) * | 1994-04-06 | 1997-10-03 | Defarges Alain Moreau | Improvements made to a needleless jet injection device. |
US6474369B2 (en) | 1995-05-26 | 2002-11-05 | Penjet Corporation | Apparatus and method for delivering a lyophilized active with a needle-less injector |
US5899879A (en) * | 1995-12-19 | 1999-05-04 | Genesis Medical Technologies, Inc. | Spring-actuated needleless injector |
US5921967A (en) | 1996-02-29 | 1999-07-13 | Medi-Ject Corporation | Plunger for nozzle assembly |
US5800388A (en) | 1996-02-29 | 1998-09-01 | Medi-Ject Corporation | Plunger/ram assembly adapted for a fluid injector |
US6374255B1 (en) | 1996-05-21 | 2002-04-16 | Immersion Corporation | Haptic authoring |
US6458574B1 (en) | 1996-09-12 | 2002-10-01 | Transkaryotic Therapies, Inc. | Treatment of a α-galactosidase a deficiency |
US5875976A (en) * | 1996-12-24 | 1999-03-02 | Medi-Ject Corporation | Locking mechanism for nozzle assembly |
US7347840B2 (en) * | 2000-03-02 | 2008-03-25 | Pyng Medical Corp. | Patch for locating a target zone for penetration |
US6761726B1 (en) * | 1998-05-15 | 2004-07-13 | Pyng Medical Corp. | Method and apparatus for the intraosseous introduction of a device such as an infusion tube |
US5911703A (en) * | 1997-05-22 | 1999-06-15 | Avant Drug Delivery Systems, Inc. | Two-stage fluid medicament jet injector |
US6030399A (en) * | 1997-06-04 | 2000-02-29 | Spectrx, Inc. | Fluid jet blood sampling device and methods |
US5947928A (en) * | 1997-06-19 | 1999-09-07 | Mile Creek Capital, Llc | Drug delivery system |
US6004287A (en) * | 1997-09-23 | 1999-12-21 | Loomis; Dale J | Biolistic apparatus for delivering substances into cells and tissues |
US6071272A (en) * | 1997-10-28 | 2000-06-06 | Hoffman; Alan S. | Method for treating erectile dysfunctionality |
US6256011B1 (en) | 1997-12-03 | 2001-07-03 | Immersion Corporation | Multi-function control device with force feedback |
US6610042B2 (en) | 1997-12-05 | 2003-08-26 | Felton Medical, Inc. | Disposable unit-dose jet-injection syringe for pre-filled and/or transfilled liquid injectable medical drug or vaccine products and method thereof |
US6503231B1 (en) * | 1998-06-10 | 2003-01-07 | Georgia Tech Research Corporation | Microneedle device for transport of molecules across tissue |
CA2330207C (en) * | 1998-06-10 | 2005-08-30 | Georgia Tech Research Corporation | Microneedle devices and methods of manufacture and use thereof |
US6428528B2 (en) | 1998-08-11 | 2002-08-06 | Antares Pharma, Inc. | Needle assisted jet injector |
US6506177B2 (en) * | 1998-10-14 | 2003-01-14 | Sergio Landau | Needle-less injection system |
US6406455B1 (en) * | 1998-12-18 | 2002-06-18 | Biovalve Technologies, Inc. | Injection devices |
DE19859137C1 (en) * | 1998-12-21 | 2000-05-18 | Ferton Holding Sa | High pressure medicinal injection unit includes piston advanced into pressure chamber by series of resilient impacts, forcing fluid out in series of impulses for precise low-volume dosing |
US6258062B1 (en) | 1999-02-25 | 2001-07-10 | Joseph M. Thielen | Enclosed container power supply for a needleless injector |
US7060048B1 (en) * | 1999-04-16 | 2006-06-13 | Powerject Research Limited | Needleless syringe |
AU4656000A (en) * | 1999-04-22 | 2000-11-10 | Gilbert Garitano | Needleless permanent makeup and tattoo device |
US7171264B1 (en) * | 1999-05-10 | 2007-01-30 | Genetronics, Inc. | Intradermal delivery of active agents by needle-free injection and electroporation |
US7192713B1 (en) | 1999-05-18 | 2007-03-20 | President And Fellows Of Harvard College | Stabilized compounds having secondary structure motifs |
EP1754488A1 (en) | 1999-05-24 | 2007-02-21 | Introgen Therapeutics, Inc. | Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases |
US6611707B1 (en) | 1999-06-04 | 2003-08-26 | Georgia Tech Research Corporation | Microneedle drug delivery device |
US6743211B1 (en) * | 1999-11-23 | 2004-06-01 | Georgia Tech Research Corporation | Devices and methods for enhanced microneedle penetration of biological barriers |
EP1220697B1 (en) | 1999-10-11 | 2004-12-29 | Felton International, Inc. | Universal anti-infectious protector for needleless injectors |
US7074210B2 (en) * | 1999-10-11 | 2006-07-11 | Felton International, Inc. | Universal protector cap with auto-disable features for needle-free injectors |
US6776776B2 (en) * | 1999-10-14 | 2004-08-17 | Becton, Dickinson And Company | Prefillable intradermal delivery device |
US6569123B2 (en) | 1999-10-14 | 2003-05-27 | Becton, Dickinson And Company | Prefillable intradermal injector |
US20020193740A1 (en) | 1999-10-14 | 2002-12-19 | Alchas Paul G. | Method of intradermally injecting substances |
US6843781B2 (en) * | 1999-10-14 | 2005-01-18 | Becton, Dickinson And Company | Intradermal needle |
US6569143B2 (en) | 1999-10-14 | 2003-05-27 | Becton, Dickinson And Company | Method of intradermally injecting substances |
US6494865B1 (en) | 1999-10-14 | 2002-12-17 | Becton Dickinson And Company | Intradermal delivery device including a needle assembly |
US6382204B1 (en) | 1999-10-14 | 2002-05-07 | Becton Dickinson And Company | Drug delivery system including holder and drug container |
CN1236826C (en) | 1999-10-22 | 2006-01-18 | 安塔雷斯制药公司 | Medical injector and medicament loading system for use therewith |
US6673035B1 (en) * | 1999-10-22 | 2004-01-06 | Antares Pharma, Inc. | Medical injector and medicament loading system for use therewith |
US6391003B1 (en) | 1999-10-25 | 2002-05-21 | Antares Pharma, Inc. | Locking mechanism for a jet injector |
US6770054B1 (en) | 1999-11-23 | 2004-08-03 | Felton International, Inc. | Injector assembly with driving means and locking means |
US7029457B2 (en) * | 1999-11-23 | 2006-04-18 | Felton International, Inc. | Jet injector with hand piece |
US7887506B1 (en) | 1999-11-23 | 2011-02-15 | Pulse Needlefree Systems, Inc. | Safety mechanism to prevent accidental patient injection and methods of same |
US6693626B1 (en) | 1999-12-07 | 2004-02-17 | Immersion Corporation | Haptic feedback using a keyboard device |
WO2001051109A1 (en) * | 2000-01-07 | 2001-07-19 | Biovalve Technologies, Inc. | Injection device |
CA2331030A1 (en) * | 2000-02-16 | 2001-08-16 | Roche Diagnostics Gmbh | Hypodermic needleless injection system |
US6689092B2 (en) * | 2000-03-03 | 2004-02-10 | Boehringer International Gmbh | Needle-less injector of miniature type |
EP1265663B1 (en) * | 2000-03-23 | 2011-03-02 | Antares Pharma, Inc. | Single use disposable jet injector |
GB0008494D0 (en) | 2000-04-07 | 2000-05-24 | Secr Defence | Microprojectile delivery system |
US10293056B1 (en) | 2000-05-24 | 2019-05-21 | Board Of Regents, The University Of Texas System | Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases |
US6629958B1 (en) | 2000-06-07 | 2003-10-07 | Ronald P. Spinello | Leak sealing needle |
US6406456B1 (en) | 2000-06-08 | 2002-06-18 | Avant Drug Delivery Systems, Inc. | Jet injector |
US20020046486A1 (en) * | 2000-07-10 | 2002-04-25 | Wild Peter M. | Woody plant injection method and apparatus |
US6695817B1 (en) | 2000-07-11 | 2004-02-24 | Icu Medical, Inc. | Medical valve with positive flow characteristics |
DE10034270A1 (en) * | 2000-07-14 | 2002-02-14 | Disetronic Licensing Ag | Storage container with a metering device for the metered delivery of an injectable product to an injection device |
GB0022742D0 (en) | 2000-09-15 | 2000-11-01 | Smithkline Beecham Biolog | Vaccine |
US6610033B1 (en) * | 2000-10-13 | 2003-08-26 | Incept, Llc | Dual component medicinal polymer delivery system and methods of use |
US7575924B2 (en) | 2000-11-13 | 2009-08-18 | Research Development Foundation | Methods and compositions relating to improved lentiviral vectors and their applications |
AU2003222427B8 (en) * | 2000-11-17 | 2010-04-29 | Vascular Biogenics Ltd. | Promoters exhibiting endothelial cell specificity and methods of using same |
US8071740B2 (en) * | 2000-11-17 | 2011-12-06 | Vascular Biogenics Ltd. | Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
EP1339442A4 (en) * | 2000-11-30 | 2006-12-27 | Biovalve Technologies Inc | Injection systems |
JP2005500247A (en) * | 2000-12-07 | 2005-01-06 | ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システム | Treatment for human MDA-7 |
WO2002064193A2 (en) | 2000-12-14 | 2002-08-22 | Georgia Tech Research Corporation | Microneedle devices and production thereof |
JP5208347B2 (en) | 2001-02-23 | 2013-06-12 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | New vaccine |
US6500239B2 (en) | 2001-03-14 | 2002-12-31 | Penjet Corporation | System and method for removing dissolved gas from a solution |
GB0109297D0 (en) | 2001-04-12 | 2001-05-30 | Glaxosmithkline Biolog Sa | Vaccine |
US6613010B2 (en) * | 2001-04-13 | 2003-09-02 | Penjet Corporation | Modular gas-pressured needle-less injector |
US20050192530A1 (en) * | 2001-04-13 | 2005-09-01 | Penjet Corporation | Method and apparatus for needle-less injection with a degassed fluid |
US6755220B2 (en) | 2001-04-27 | 2004-06-29 | Penjet Corporation | Method and apparatus for filling or refilling a needle-less injector |
US20100221284A1 (en) | 2001-05-30 | 2010-09-02 | Saech-Sisches Serumwerk Dresden | Novel vaccine composition |
MY134424A (en) | 2001-05-30 | 2007-12-31 | Saechsisches Serumwerk | Stable influenza virus preparations with low or no amount of thiomersal |
US6752781B2 (en) * | 2001-06-08 | 2004-06-22 | Sergio Landau | Durable hypodermic jet injector apparatus and method |
DE10129583A1 (en) * | 2001-06-20 | 2003-01-09 | Disetronic Licensing Ag | Device and method for injection |
JP2004531578A (en) * | 2001-06-29 | 2004-10-14 | ベクトン・ディキンソン・アンド・カンパニー | Intradermal delivery of vaccines and gene therapeutics by microcannula |
US20060018877A1 (en) * | 2001-06-29 | 2006-01-26 | Mikszta John A | Intradermal delivery of vacccines and therapeutic agents |
JP4792670B2 (en) * | 2001-07-23 | 2011-10-12 | 株式会社島津製作所 | Needleless syringe |
ATE527347T1 (en) * | 2001-08-02 | 2011-10-15 | Inst Clayton De La Rech | METHODS AND COMPOSITIONS RELATED TO IMPROVED LENTIVIRUS VECTOR PRODUCTION SYSTEMS |
CA2456484A1 (en) | 2001-08-17 | 2003-02-27 | Antares Pharma, Inc. | Administration of insulin by jet injection |
US7615234B2 (en) | 2001-09-11 | 2009-11-10 | Glide Pharmaceutical Technologies Limited | Drug delivery technology |
GB2404865B (en) * | 2001-09-11 | 2005-09-28 | Caretek Medical Ltd | Novel drug delivery technology |
GB2391480B (en) * | 2002-08-05 | 2007-02-28 | Caretek Medical Ltd | Drug delivery system |
US8361037B2 (en) * | 2001-09-19 | 2013-01-29 | Valeritas, Inc. | Microneedles, microneedle arrays, and systems and methods relating to same |
WO2003024508A2 (en) * | 2001-09-21 | 2003-03-27 | Biovalve Technologies, Inc. | Gas pressure actuated microneedle arrays, and systems and methods relating to same |
US20030135201A1 (en) * | 2001-09-28 | 2003-07-17 | Gonnelli Robert R. | Microneedle with membrane |
CA2500452A1 (en) * | 2001-09-28 | 2003-04-03 | Biovalve Technologies, Inc. | Switchable microneedle arrays and systems and methods relating to same |
NZ532060A (en) * | 2001-10-02 | 2005-11-25 | Inst Clayton De La Rech | Methods and compositions relating to restricted expression lentiviral vectors and their applications |
AU2002307793B2 (en) | 2001-10-19 | 2007-01-25 | Vascular Biogenics Ltd. | Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
US6824526B2 (en) | 2001-10-22 | 2004-11-30 | Penjet Corporation | Engine and diffuser for use with a needle-less injector |
GB0125506D0 (en) | 2001-10-24 | 2001-12-12 | Weston Medical Ltd | Needle free injection method and apparatus |
US6607510B2 (en) * | 2001-11-09 | 2003-08-19 | Bioject Medical Technologies Inc. | Disposable needle-free injection apparatus and method |
US20030130614A1 (en) * | 2002-01-09 | 2003-07-10 | Johnson Lanny L. | Device for delivering liquid medications or nutrients and gases to local tissue |
GB2384527B (en) * | 2002-01-23 | 2004-07-14 | Bespak Plc | Dispensing device |
US6875205B2 (en) | 2002-02-08 | 2005-04-05 | Alaris Medical Systems, Inc. | Vial adapter having a needle-free valve for use with vial closures of different sizes |
AU2003228267A1 (en) * | 2002-03-05 | 2003-09-22 | Board Of Regents, The University Of Texas System | Methods of enhancing immune induction involving mda-7 |
US6904823B2 (en) | 2002-04-03 | 2005-06-14 | Immersion Corporation | Haptic shifting devices |
WO2003086278A2 (en) | 2002-04-05 | 2003-10-23 | Board Of Regents, The University Of Texas System | Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions |
ATE514430T1 (en) | 2002-04-25 | 2011-07-15 | Shire Human Genetic Therapies | TREATMENT OF ALPHA-GALACTOSIDASE A DEFICIENCY |
CA2484166C (en) * | 2002-04-26 | 2011-11-29 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Improved chimeric glycoproteins and pseudotyped lentiviral vectors |
US20040025420A1 (en) * | 2002-05-09 | 2004-02-12 | Peter M. Wild | Injection needle for injecting woody plants |
US6942638B1 (en) * | 2002-05-30 | 2005-09-13 | Kerry Quinn | Needleless injector and ampule system |
US9072543B2 (en) | 2002-05-31 | 2015-07-07 | Vidacare LLC | Vascular access kits and methods |
US9545243B2 (en) | 2002-05-31 | 2017-01-17 | Vidacare LLC | Bone marrow aspiration devices and related methods |
US20070049945A1 (en) | 2002-05-31 | 2007-03-01 | Miller Larry J | Apparatus and methods to install, support and/or monitor performance of intraosseous devices |
WO2008033871A2 (en) * | 2006-09-12 | 2008-03-20 | Vidacare Corporation | Apparatus and methods for biopsy and aspiration of bone marrow |
US11298202B2 (en) | 2002-05-31 | 2022-04-12 | Teleflex Life Sciences Limited | Biopsy devices and related methods |
US8641715B2 (en) | 2002-05-31 | 2014-02-04 | Vidacare Corporation | Manual intraosseous device |
US11337728B2 (en) | 2002-05-31 | 2022-05-24 | Teleflex Life Sciences Limited | Powered drivers, intraosseous devices and methods to access bone marrow |
EP3292821A1 (en) | 2002-05-31 | 2018-03-14 | Vidacare LLC | Apparatus and method to access bone marrow |
US7811260B2 (en) | 2002-05-31 | 2010-10-12 | Vidacare Corporation | Apparatus and method to inject fluids into bone marrow and other target sites |
US8142365B2 (en) * | 2002-05-31 | 2012-03-27 | Vidacare Corporation | Apparatus and method for accessing the bone marrow of the sternum |
US7951089B2 (en) * | 2002-05-31 | 2011-05-31 | Vidacare Corporation | Apparatus and methods to harvest bone and bone marrow |
WO2008033874A2 (en) | 2006-09-12 | 2008-03-20 | Vidacare Corporation | Bone marrow aspiration devices and related methods |
US10973532B2 (en) | 2002-05-31 | 2021-04-13 | Teleflex Life Sciences Limited | Powered drivers, intraosseous devices and methods to access bone marrow |
US8668698B2 (en) | 2002-05-31 | 2014-03-11 | Vidacare Corporation | Assembly for coupling powered driver with intraosseous device |
US10973545B2 (en) | 2002-05-31 | 2021-04-13 | Teleflex Life Sciences Limited | Powered drivers, intraosseous devices and methods to access bone marrow |
US8690791B2 (en) | 2002-05-31 | 2014-04-08 | Vidacare Corporation | Apparatus and method to access the bone marrow |
WO2008033873A2 (en) | 2006-09-12 | 2008-03-20 | Vidacare Corporation | Medical procedures trays and related methods |
US9314228B2 (en) | 2002-05-31 | 2016-04-19 | Vidacare LLC | Apparatus and method for accessing the bone marrow |
AU2003247707A1 (en) * | 2002-07-03 | 2004-01-23 | Peter M. Wild | Plant injection method and apparatus |
WO2004014314A2 (en) | 2002-08-12 | 2004-02-19 | David Kirn | Methods and compositions concerning poxviruses and cancer |
US8917234B2 (en) | 2002-10-15 | 2014-12-23 | Immersion Corporation | Products and processes for providing force sensations in a user interface |
WO2004041331A1 (en) * | 2002-11-01 | 2004-05-21 | Antares Pharma, Inc. | Administration of insulin by jet injection |
WO2004048583A2 (en) * | 2002-11-22 | 2004-06-10 | Institut Clayton De La Recherche | Compositions and systems for the regulation of genes |
DK2441467T3 (en) | 2003-01-31 | 2015-08-31 | Sinai School Medicine | Combination therapy for the treatment of protein deficiency disorders |
WO2004078124A2 (en) * | 2003-03-03 | 2004-09-16 | Board Of Regents, The University Of Texas System | Methods and compositions involving mda-7 |
US6802455B1 (en) * | 2003-03-26 | 2004-10-12 | Willie V. Evans | Atomizer |
FR2853837B1 (en) * | 2003-04-16 | 2006-01-13 | Crossject | DEVICE FOR CONNECTING AN ACTIVE PRINCIPLE RESERVOIR TO AN INJECTION NOZZLE IN A DEVICE FOR INJECTING SAID ACTIVE PRINCIPLE |
WO2004110533A1 (en) * | 2003-05-09 | 2004-12-23 | Anges Mg, Inc. | Needleless syringe having medical agent accommodated therein |
AU2004272972A1 (en) | 2003-05-22 | 2005-03-24 | Fraunhofer Usa, Inc. | Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
US9504477B2 (en) | 2003-05-30 | 2016-11-29 | Vidacare LLC | Powered driver |
US8992322B2 (en) | 2003-06-09 | 2015-03-31 | Immersion Corporation | Interactive gaming systems with haptic feedback |
HU225252B1 (en) * | 2003-08-21 | 2006-08-28 | S Istvan Lindmayer | Needleless injection apparatus |
WO2005034949A1 (en) * | 2003-09-09 | 2005-04-21 | University Of Florida | Desferrithiocin derivatives and their use as iron chelators |
US8034790B2 (en) * | 2003-12-01 | 2011-10-11 | Introgen Therapeutics | Use of MDA-7 to inhibit pathogenic infectious organisms |
US7815642B2 (en) * | 2004-01-26 | 2010-10-19 | Vidacare Corporation | Impact-driven intraosseous needle |
EP1722842A1 (en) * | 2004-01-26 | 2006-11-22 | The Medical House Plc | Needle-free injection device |
ATE425705T1 (en) | 2004-01-26 | 2009-04-15 | Vidacare Corp | MANUAL INTEROSSARY DEVICE |
US20070281041A1 (en) * | 2004-03-02 | 2007-12-06 | Introgen Therapeutics, Inc. | Compositions and Methods Involving MDA-7 for the Treatment of Cancer |
DE102004017971A1 (en) * | 2004-04-12 | 2005-10-27 | Leica Microsystems (Schweiz) Ag | Stand, especially for surgical microscopes, with a force storage element |
DE102004017970A1 (en) * | 2004-04-12 | 2005-10-27 | Leica Microsystems (Schweiz) Ag | Stand, especially for surgical microscopes, with a force storage element |
DE102005018305A1 (en) * | 2004-05-25 | 2005-12-22 | Tecpharma Licensing Ag | Dosing unit comprises a dose-adjusting unit, which is rotated to adjust the dose, and a graduated scale |
GB2414404B (en) | 2004-05-28 | 2009-06-03 | Cilag Ag Int | Injection device |
GB2414400B (en) * | 2004-05-28 | 2009-01-14 | Cilag Ag Int | Injection device |
GB2414399B (en) * | 2004-05-28 | 2008-12-31 | Cilag Ag Int | Injection device |
GB2414401B (en) | 2004-05-28 | 2009-06-17 | Cilag Ag Int | Injection device |
GB2414775B (en) * | 2004-05-28 | 2008-05-21 | Cilag Ag Int | Releasable coupling and injection device |
GB2414409B (en) * | 2004-05-28 | 2009-11-18 | Cilag Ag Int | Injection device |
GB2414403B (en) * | 2004-05-28 | 2009-01-07 | Cilag Ag Int | Injection device |
GB2414406B (en) | 2004-05-28 | 2009-03-18 | Cilag Ag Int | Injection device |
GB2414402B (en) * | 2004-05-28 | 2009-04-22 | Cilag Ag Int | Injection device |
GB2414405B (en) * | 2004-05-28 | 2009-01-14 | Cilag Ag Int | Injection device |
US7717874B2 (en) * | 2004-05-28 | 2010-05-18 | Bioject, Inc. | Needle-free injection system |
US20070299392A1 (en) * | 2004-07-14 | 2007-12-27 | By-Pass, Inc. | Material Delivery System |
US7615041B2 (en) * | 2004-07-29 | 2009-11-10 | Boston Scientific Scimed, Inc. | Vial adaptor |
JP4059238B2 (en) * | 2004-09-16 | 2008-03-12 | ソニー株式会社 | Digital signal processing apparatus and digital signal processing method |
KR101508563B1 (en) | 2004-09-22 | 2015-04-07 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | Immunogenic composition for use in vaccination against staphylococcei |
US20060089594A1 (en) * | 2004-10-26 | 2006-04-27 | Sergio Landau | Needle-free injection device |
US20060089593A1 (en) * | 2004-10-26 | 2006-04-27 | Sergio Landau | Needle-free injection device for individual users |
WO2007001448A2 (en) * | 2004-11-04 | 2007-01-04 | Massachusetts Institute Of Technology | Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals |
JP2008518719A (en) | 2004-11-05 | 2008-06-05 | アイシーユー メディカル インコーポレイテッド | Medical soft grip connector |
US8998848B2 (en) * | 2004-11-12 | 2015-04-07 | Vidacare LLC | Intraosseous device and methods for accessing bone marrow in the sternum and other target areas |
CA2891057C (en) | 2004-11-22 | 2018-11-13 | Kaleo, Inc. | Medicament delivery apparatus and movable indicator |
WO2006058426A1 (en) * | 2004-12-01 | 2006-06-08 | Wlt Distributors Inc. | Needle-free injector |
JP4948422B2 (en) | 2005-02-01 | 2012-06-06 | インテリジェクト,インコーポレイテッド | Drug delivery apparatus, system and method |
GB2422784A (en) * | 2005-02-07 | 2006-08-09 | Caretek Medical Ltd | Disposable assembly comprising a needle or stylet |
JP2008531481A (en) * | 2005-02-08 | 2008-08-14 | ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システム | Compositions and methods comprising MDA-7 for the treatment of cancer |
CA2601022C (en) | 2005-03-23 | 2023-03-07 | Glaxosmithkline Biologicals S.A. | Use of an influenza virus an oil-in-water emulsion adjuvant to induce cd4 t-cell and/or improved b-memory cell response |
TR201910900T4 (en) | 2005-04-04 | 2019-08-21 | Univ Florida | Desferritiokine polyether analogs. |
GB2424836B (en) * | 2005-04-06 | 2010-09-22 | Cilag Ag Int | Injection device (bayonet cap removal) |
GB2424837B (en) * | 2005-04-06 | 2010-10-06 | Cilag Ag Int | Injection device |
GB2424838B (en) * | 2005-04-06 | 2011-02-23 | Cilag Ag Int | Injection device (adaptable drive) |
GB2425062B (en) * | 2005-04-06 | 2010-07-21 | Cilag Ag Int | Injection device |
GB2424835B (en) * | 2005-04-06 | 2010-06-09 | Cilag Ag Int | Injection device (modified trigger) |
GB2427826B (en) * | 2005-04-06 | 2010-08-25 | Cilag Ag Int | Injection device comprising a locking mechanism associated with integrally formed biasing means |
US7699802B2 (en) * | 2005-05-03 | 2010-04-20 | Pharmajet, Inc. | Needle-less injector |
US20070027428A1 (en) * | 2005-05-03 | 2007-02-01 | Pharmajet, Inc. | Vial system and method for needle-less injector |
US7618393B2 (en) * | 2005-05-03 | 2009-11-17 | Pharmajet, Inc. | Needle-less injector and method of fluid delivery |
EP1896083B1 (en) | 2005-05-17 | 2016-03-02 | Amicus Therapeutics, Inc. | A method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives |
US20100119525A1 (en) * | 2005-08-01 | 2010-05-13 | Mount Sinai Schoool Of Medicine Of New York University | Method for extending longevity using npc1l1 antagonists |
BRPI0614475B8 (en) | 2005-08-03 | 2021-05-25 | Fraunhofer Usa Inc | polypeptide, antibody, nucleic acid, vectors, host cell, antibody composition and production processes |
US8591457B2 (en) * | 2005-08-10 | 2013-11-26 | Alza Corporation | Method for making a needle-free jet injection drug delivery device |
PT1759729E (en) * | 2005-08-30 | 2010-03-04 | Cilag Gmbh Int | Needle assembly for a prefilled syringe system |
US8980246B2 (en) | 2005-09-07 | 2015-03-17 | Sillajen Biotherapeutics, Inc. | Oncolytic vaccinia virus cancer therapy |
WO2007030668A2 (en) | 2005-09-07 | 2007-03-15 | Jennerex Biotherapeutics Ulc | Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing poxviruses |
US20110098656A1 (en) * | 2005-09-27 | 2011-04-28 | Burnell Rosie L | Auto-injection device with needle protecting cap having outer and inner sleeves |
EP1933930B1 (en) * | 2005-10-13 | 2019-06-19 | Argos Therapeutics, Inc. | A medicament holding device |
TWI457133B (en) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | Novel composition |
WO2007070682A2 (en) * | 2005-12-15 | 2007-06-21 | Massachusetts Institute Of Technology | System for screening particles |
US7988660B2 (en) * | 2005-12-20 | 2011-08-02 | Eli Lilly And Company | Needle-free injection device |
DE102005062220B3 (en) * | 2005-12-20 | 2007-02-15 | Primojex Gmbh | System for needle-free or needle injection of fluid, e.g. medicament, comprises injection device connectable to needle attachment separable into cannula and adapter parts, allowing changing of needles |
CA2816182C (en) | 2005-12-22 | 2018-02-20 | Glaxosmithkline Biologicals S.A. | Pneumococcal polysaccharide conjugate vaccine |
GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
US20080161755A1 (en) * | 2006-01-27 | 2008-07-03 | Bioject Inc. | Needle-free injection device and priming system |
WO2007092944A2 (en) * | 2006-02-08 | 2007-08-16 | Introgen Therapeutics, Inc. | Compositions and methods involving gene therapy and proteasome modulation |
CA2642056A1 (en) * | 2006-02-13 | 2007-08-23 | Fraunhofer Usa, Inc. | Hpv antigens, vaccine compositions, and related methods |
US8277816B2 (en) * | 2006-02-13 | 2012-10-02 | Fraunhofer Usa, Inc. | Bacillus anthracis antigens, vaccine compositions, and related methods |
KR20080106433A (en) * | 2006-02-13 | 2008-12-05 | 프라운호퍼 유에스에이, 인코포레이티드 | Influenza antigens, vaccine compositions, and related methods |
EP1998684A4 (en) * | 2006-03-10 | 2014-09-17 | Massachusetts Inst Technology | Triggered self-assembly conjugates and nanosystems |
WO2007111806A2 (en) * | 2006-03-23 | 2007-10-04 | Massachusetts Eye And Ear Infirmary | Cyclopentane heptanoic acid compounds for reducing body fat |
US20100021503A1 (en) | 2006-03-30 | 2010-01-28 | Glaxosmithkline Biologicals S.A. | Immunogenic composition |
WO2008105773A2 (en) | 2006-03-31 | 2008-09-04 | Massachusetts Institute Of Technology | System for targeted delivery of therapeutic agents |
US20090325944A1 (en) * | 2006-04-12 | 2009-12-31 | Suzanne Walker Kahne | Methods and Compositions for Modulating Glycosylation |
CA2652280C (en) | 2006-05-15 | 2014-01-28 | Massachusetts Institute Of Technology | Polymers for functional particles |
US20110052697A1 (en) * | 2006-05-17 | 2011-03-03 | Gwangju Institute Of Science & Technology | Aptamer-Directed Drug Delivery |
GB2438590B (en) | 2006-06-01 | 2011-02-09 | Cilag Gmbh Int | Injection device |
GB2438591B (en) * | 2006-06-01 | 2011-07-13 | Cilag Gmbh Int | Injection device |
GB2438593B (en) | 2006-06-01 | 2011-03-30 | Cilag Gmbh Int | Injection device (cap removal feature) |
ES2570334T3 (en) | 2006-06-02 | 2016-05-17 | Harvard College | Surface protein remodeling |
WO2007150030A2 (en) | 2006-06-23 | 2007-12-27 | Massachusetts Institute Of Technology | Microfluidic synthesis of organic nanoparticles |
US7824360B2 (en) * | 2006-06-28 | 2010-11-02 | Zion Azar | Intradermal needles injection device |
CN105727276A (en) | 2006-07-17 | 2016-07-06 | 葛兰素史密丝克莱恩生物有限公司 | Influenza vaccine |
US9115358B2 (en) * | 2006-08-11 | 2015-08-25 | President And Fellows Of Harvard College | Moenomycin biosynthesis-related compositions and methods of use thereof |
US20090269342A1 (en) * | 2006-08-14 | 2009-10-29 | Massachusetts Institute Of Technology | Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto |
JP2010500880A (en) * | 2006-08-14 | 2010-01-14 | マサチューセッツ・インスティテュート・オブ・テクノロジー | Hemagglutinin polypeptide and reagents and methods related to hemagglutinin polypeptide |
US8944069B2 (en) | 2006-09-12 | 2015-02-03 | Vidacare Corporation | Assemblies for coupling intraosseous (IO) devices to powered drivers |
KR20150044979A (en) | 2006-09-13 | 2015-04-27 | 임머숀 코퍼레이션 | Systems and methods for casino gaming haptics |
CA2921063C (en) | 2006-09-15 | 2020-01-28 | Ottawa Hospital Research Institute | Oncolytic rhabdovirus |
US7547293B2 (en) * | 2006-10-06 | 2009-06-16 | Bioject, Inc. | Triggering mechanism for needle-free injector |
JO3598B1 (en) * | 2006-10-10 | 2020-07-05 | Infinity Discovery Inc | Boronic acids and esters as inhibitors of fatty acid amide hydrolase |
EP2433648A3 (en) | 2006-10-12 | 2012-04-04 | GlaxoSmithKline Biologicals S.A. | Vaccine comprising an oil in water emulsion adjuvant |
BRPI0717219B8 (en) | 2006-10-12 | 2021-05-25 | Glaxosmithkline Biologicals Sa | immunogenic composition, and, use of an immunogenic composition |
US7780201B2 (en) * | 2006-10-13 | 2010-08-24 | Medela Holding Ag | Tube connector with three part construction and latching component |
US8105314B2 (en) | 2006-10-25 | 2012-01-31 | Icu Medical, Inc. | Medical connector |
US8974410B2 (en) | 2006-10-30 | 2015-03-10 | Vidacare LLC | Apparatus and methods to communicate fluids and/or support intraosseous devices |
US20100303723A1 (en) * | 2006-11-20 | 2010-12-02 | Massachusetts Institute Of Technology | Drug delivery systems using fc fragments |
US20100150994A1 (en) | 2006-12-01 | 2010-06-17 | Anterios, Inc. | Amphiphilic entity nanoparticles |
AU2007333225B2 (en) * | 2006-12-08 | 2014-06-12 | Massachusetts Institute Of Technology | Delivery of nanoparticles and/or agents to cells |
US20080140001A1 (en) * | 2006-12-12 | 2008-06-12 | By-Pass Inc. | Fluid Delivery Apparatus And Methods |
TWI618544B (en) | 2006-12-26 | 2018-03-21 | 藍瑟斯醫學影像公司 | Ligands for imaging cardiac innervation |
PT2118123E (en) | 2007-01-31 | 2016-02-10 | Harvard College | Stabilized p53 peptides and uses thereof |
WO2008098165A2 (en) * | 2007-02-09 | 2008-08-14 | Massachusetts Institute Of Technology | Oscillating cell culture bioreactor |
DE102007008597A1 (en) | 2007-02-19 | 2008-08-21 | Primojex Gmbh | Fluid injecting system for use through or into epidermis or corium of human skin, has mounting device protecting ampoule body of syringe, and injection device axially adjusting ampoule piston corresponding to given pressure profile |
WO2008103997A2 (en) * | 2007-02-23 | 2008-08-28 | Bioject Inc. | Needle-free injection devices and drug delivery systems therefor |
KR20080084528A (en) | 2007-03-15 | 2008-09-19 | 제네렉스 바이오테라퓨틱스 인크. | Oncolytic vaccinia virus cancer therapy |
CA2680592C (en) | 2007-03-15 | 2016-07-05 | University Of Florida Research Foundation, Inc. | Desferrithiocin polyether analogues and uses thereof in treating pathological conditions |
US7960139B2 (en) | 2007-03-23 | 2011-06-14 | Academia Sinica | Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells |
EP2508531B1 (en) | 2007-03-28 | 2016-10-19 | President and Fellows of Harvard College | Stitched polypeptides |
WO2008124463A2 (en) | 2007-04-04 | 2008-10-16 | Vidacare Corporation | Powered drivers, intraosseous devices and methods to access bone marrow |
EP2144600A4 (en) | 2007-04-04 | 2011-03-16 | Massachusetts Inst Technology | Poly (amino acid) targeting moieties |
WO2008124634A1 (en) | 2007-04-04 | 2008-10-16 | Massachusetts Institute Of Technology | Polymer-encapsulated reverse micelles |
CA2685558A1 (en) * | 2007-04-28 | 2008-11-06 | Fraunhofer Usa, Inc. | Trypanosoma antigens, vaccine compositions, and related methods |
US20100191215A1 (en) * | 2007-06-12 | 2010-07-29 | By-Pass ,Inc. | Pressure pulse actuating device for delivery systems |
DK2175881T3 (en) * | 2007-06-14 | 2012-10-22 | Crucell Switzerland Ag | Intradermal influenza vaccine |
US8524444B2 (en) | 2007-06-15 | 2013-09-03 | President And Fellows Of Harvard College | Methods and compositions for detections and modulating O-glycosylation |
KR101579947B1 (en) | 2007-06-26 | 2015-12-28 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
CA2692933C (en) * | 2007-07-11 | 2016-10-18 | Fraunhofer Usa, Inc. | Yersinia pestis antigens, vaccine compositions, and related methods |
CN101820903A (en) * | 2007-08-20 | 2010-09-01 | 美国弗劳恩霍夫股份有限公司 | Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods |
EP2188004A4 (en) | 2007-08-21 | 2015-06-17 | Yukon Medical Llc | Vial access and injection system |
EP2205074A4 (en) * | 2007-10-04 | 2013-07-31 | Harvard College | Moenomycin analogs, methods of synthesis, and uses thereof |
US8172797B2 (en) * | 2007-10-10 | 2012-05-08 | Shl Group Ab | Medical delivery device |
ES2627233T3 (en) | 2007-10-12 | 2017-07-27 | Massachusetts Institute Of Technology | Vaccine Nanotechnology |
WO2009086250A1 (en) * | 2007-12-21 | 2009-07-09 | Aesthetic Sciences Corporation | Self-contained pressurized injection device |
EP2237787A4 (en) * | 2008-01-03 | 2012-03-21 | Massachusetts Inst Technology | Decoy influenza therapies |
US8193182B2 (en) | 2008-01-04 | 2012-06-05 | Intellikine, Inc. | Substituted isoquinolin-1(2H)-ones, and methods of use thereof |
DE102008008023A1 (en) | 2008-02-04 | 2009-08-13 | Primojex Gmbh | System for injecting a fluid through or into the human skin |
US9486292B2 (en) | 2008-02-14 | 2016-11-08 | Immersion Corporation | Systems and methods for real-time winding analysis for knot detection |
WO2009114542A1 (en) | 2008-03-10 | 2009-09-17 | Antares Pharma, Inc. | Injector safety device |
US9117870B2 (en) * | 2008-03-27 | 2015-08-25 | Lam Research Corporation | High throughput cleaner chamber |
US8936571B2 (en) * | 2008-03-31 | 2015-01-20 | Laura Devega | Illuminated syringe |
EP2271387B1 (en) * | 2008-04-01 | 2016-06-15 | Yukon Medical, LLC | Dual container fluid transfer device |
CA2721060A1 (en) * | 2008-04-09 | 2009-10-15 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase |
MX2010011412A (en) | 2008-04-16 | 2010-11-12 | Glaxosmithkline Biolog Sa | Vaccine. |
AU2009243187C1 (en) * | 2008-04-28 | 2015-12-24 | President And Fellows Of Harvard College | Supercharged proteins for cell penetration |
GB2461086B (en) * | 2008-06-19 | 2012-12-05 | Cilag Gmbh Int | Injection device |
GB2461088B (en) * | 2008-06-19 | 2012-09-26 | Cilag Gmbh Int | Injection device |
GB2461084B (en) * | 2008-06-19 | 2012-09-26 | Cilag Gmbh Int | Fluid transfer assembly |
GB2461085B (en) * | 2008-06-19 | 2012-08-29 | Cilag Gmbh Int | Injection device |
GB2461089B (en) * | 2008-06-19 | 2012-09-19 | Cilag Gmbh Int | Injection device |
GB2461087B (en) * | 2008-06-19 | 2012-09-26 | Cilag Gmbh Int | Injection device |
WO2009158687A1 (en) | 2008-06-26 | 2009-12-30 | Anterios, Inc. | Dermal delivery |
DK2318832T3 (en) | 2008-07-15 | 2014-01-20 | Academia Sinica | Glycan arrays on PTFE-like aluminum coated slides and related methods |
US20110144306A1 (en) * | 2008-07-23 | 2011-06-16 | President And Fellows Of Harvard College | Ligation of stapled polypeptides |
CA2734991A1 (en) * | 2008-07-23 | 2010-01-28 | Massachusetts Institute Of Technology | Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival |
US20100021472A1 (en) * | 2008-07-25 | 2010-01-28 | Geetha Srikrishna | Methods for diagnosing and treating cancer |
AU2009279719B2 (en) | 2008-08-05 | 2015-07-23 | Antares Pharma, Inc. | Multiple dosage injector |
WO2010037046A1 (en) | 2008-09-28 | 2010-04-01 | Fraunhofer Usa, Inc. | Humanized neuraminidase antibody and methods of use thereof |
US8591905B2 (en) | 2008-10-12 | 2013-11-26 | The Brigham And Women's Hospital, Inc. | Nicotine immunonanotherapeutics |
US8277812B2 (en) | 2008-10-12 | 2012-10-02 | Massachusetts Institute Of Technology | Immunonanotherapeutics that provide IgG humoral response without T-cell antigen |
US8343497B2 (en) * | 2008-10-12 | 2013-01-01 | The Brigham And Women's Hospital, Inc. | Targeting of antigen presenting cells with immunonanotherapeutics |
US8343498B2 (en) * | 2008-10-12 | 2013-01-01 | Massachusetts Institute Of Technology | Adjuvant incorporation in immunonanotherapeutics |
WO2010057197A1 (en) | 2008-11-17 | 2010-05-20 | The Regents Of The University Of Michigan | Cancer vaccine compositions and methods of using the same |
WO2010077806A1 (en) | 2008-12-15 | 2010-07-08 | Greenlight Biosciences, Inc. | Methods for control of flux in metabolic pathways |
CN105132387A (en) * | 2008-12-22 | 2015-12-09 | 绿光生物科学公司 | Compositions and methods for the production of a compound |
US8454579B2 (en) | 2009-03-25 | 2013-06-04 | Icu Medical, Inc. | Medical connector with automatic valves and volume regulator |
US20100252373A1 (en) * | 2009-04-02 | 2010-10-07 | Innovative Office Products, Inc. | Friction device for a spring cylinder |
EP2416660B1 (en) | 2009-04-07 | 2014-07-02 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase |
JP2012523425A (en) | 2009-04-07 | 2012-10-04 | インフイニトイ プハルマセウトイカルス インコーポレイテッド | Inhibitors of fatty acid amide hydrolase |
NZ595629A (en) | 2009-04-09 | 2013-04-26 | Amicus Therapeutics Inc | Methods for preventing and/or treating lysosomal storage disorders |
EP3124007A1 (en) | 2009-04-14 | 2017-02-01 | Yukon Medical, LLC | Fluid transfer device |
US9221886B2 (en) | 2009-04-28 | 2015-12-29 | President And Fellows Of Harvard College | Supercharged proteins for cell penetration |
US8927551B2 (en) * | 2009-05-18 | 2015-01-06 | Infinity Pharmaceuticals, Inc. | Isoxazolines as inhibitors of fatty acid amide hydrolase |
US9149465B2 (en) * | 2009-05-18 | 2015-10-06 | Infinity Pharmaceuticals, Inc. | Isoxazolines as inhibitors of fatty acid amide hydrolase |
US8765735B2 (en) * | 2009-05-18 | 2014-07-01 | Infinity Pharmaceuticals, Inc. | Isoxazolines as inhibitors of fatty acid amide hydrolase |
US9104791B2 (en) | 2009-05-28 | 2015-08-11 | Immersion Corporation | Systems and methods for editing a model of a physical system for a simulation |
JP2012528858A (en) | 2009-06-01 | 2012-11-15 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | O-GlcNAc transferase inhibitor and use thereof |
US9163330B2 (en) | 2009-07-13 | 2015-10-20 | President And Fellows Of Harvard College | Bifunctional stapled polypeptides and uses thereof |
GB0913681D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
EP3409119B1 (en) | 2009-09-14 | 2020-08-12 | SillaJen Biotherapeutics, Inc. | Oncolytic vaccinia virus combination cancer therapy |
CA2774973A1 (en) | 2009-09-22 | 2011-03-31 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
WO2011041391A1 (en) | 2009-09-29 | 2011-04-07 | Fraunhofer Usa, Inc. | Influenza hemagglutinin antibodies, compositions, and related methods |
RU2015147509A (en) | 2009-10-19 | 2019-01-14 | Амикус Терапьютикс, Инк. | NEW COMPOSITIONS FOR PREVENTING AND / OR TREATING DEGENERATIVE DISORDERS OF THE CENTRAL NERVOUS SYSTEM |
JP6147005B2 (en) | 2009-10-19 | 2017-06-14 | アミカス セラピューティックス インコーポレイテッド | Novel composition for preventing and / or treating lysosomal storage disorders |
US10087236B2 (en) | 2009-12-02 | 2018-10-02 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
US11377485B2 (en) | 2009-12-02 | 2022-07-05 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
MX337062B (en) | 2009-12-10 | 2016-02-11 | Ottawa Hospital Res Inst | Oncolytic rhabdovirus. |
US9180127B2 (en) | 2009-12-29 | 2015-11-10 | Dana-Farber Cancer Institute, Inc. | Type II Raf kinase inhibitors |
AU2011210840B2 (en) | 2010-01-27 | 2014-12-11 | Massachusetts Institute Of Technology | Engineered polypeptide agents for targeted broad spectrum influenza neutralization |
MX361011B (en) * | 2010-02-03 | 2018-11-26 | Infinity Pharmaceuticals Inc | Fatty acid amide hydrolase inhibitors. |
WO2011112635A1 (en) | 2010-03-08 | 2011-09-15 | Sloan-Kettering Institute For Cancer Research | Cdc7 kinase inhibitors and uses thereof |
GB201003920D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Method of treatment |
GB201003922D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Conjugation process |
US9102697B2 (en) | 2010-03-22 | 2015-08-11 | President And Fellows Of Harvard College | Trioxacarcins and uses thereof |
USD644731S1 (en) | 2010-03-23 | 2011-09-06 | Icu Medical, Inc. | Medical connector |
WO2011130332A1 (en) | 2010-04-12 | 2011-10-20 | Academia Sinica | Glycan arrays for high throughput screening of viruses |
EP2566853B1 (en) | 2010-05-05 | 2017-01-25 | Infinity Pharmaceuticals, Inc. | Tetrazolones as inhibitors of fatty acid synthase |
WO2011140296A1 (en) | 2010-05-05 | 2011-11-10 | Infinity Pharmaceuticals | Triazoles as inhibitors of fatty acid synthase |
DK2566953T3 (en) | 2010-05-07 | 2019-04-15 | Greenlight Biosciences Inc | METHODS OF MANAGING THE POWER BY METABOLIC ROADS USING ENZYMOUS LOCATION |
CN106977429B (en) | 2010-05-11 | 2021-08-24 | 蓝瑟斯医学影像公司 | Compositions, methods and systems for synthesis and use of contrast agents |
US8758306B2 (en) | 2010-05-17 | 2014-06-24 | Icu Medical, Inc. | Medical connectors and methods of use |
USD655017S1 (en) | 2010-06-17 | 2012-02-28 | Yukon Medical, Llc | Shroud |
ES2664872T3 (en) | 2010-06-18 | 2018-04-23 | Taiho Pharmaceutical Co., Ltd | PRPK-TPRKB modulators and their uses |
WO2012019168A2 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
PT2603600T (en) | 2010-08-13 | 2019-02-27 | Aileron Therapeutics Inc | Peptidomimetic macrocycles |
WO2012030980A1 (en) | 2010-08-31 | 2012-03-08 | Greenlight Biosciences, Inc. | Methods for control of flux in metabolic pathways through protease manipulation |
JP2013541528A (en) | 2010-09-21 | 2013-11-14 | マサチューセッツ インスティテュート オブ テクノロジー | Human adaptive HA polypeptides, vaccines, and influenza treatment |
US8957026B2 (en) | 2010-09-22 | 2015-02-17 | President And Fellows Of Harvard College | Beta-catenin targeting peptides and uses thereof |
US20120237975A1 (en) | 2010-10-01 | 2012-09-20 | Jason Schrum | Engineered nucleic acids and methods of use thereof |
WO2012047941A2 (en) | 2010-10-04 | 2012-04-12 | Massachusetts Institute Of Technology | Hemagglutinin polypeptides, and reagents and methods relating thereto |
CN103298474B (en) | 2010-11-10 | 2016-06-29 | 无限药品股份有限公司 | Heterocyclic compound and application thereof |
WO2012068432A1 (en) * | 2010-11-19 | 2012-05-24 | Msd Consumer Care, Inc. | Click pen applicator device and method of using same |
KR101224581B1 (en) | 2010-12-10 | 2013-01-21 | 주식회사 모리스 | Cap with Automatic Sealing Structure in Tube Container |
WO2012094386A1 (en) | 2011-01-04 | 2012-07-12 | Jennerex Inc. | Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus |
EP2663350A4 (en) * | 2011-01-10 | 2018-01-24 | Zogenix, Inc. | Improved needle free injectors |
NZ612909A (en) | 2011-01-10 | 2015-09-25 | Infinity Pharmaceuticals Inc | Processes for preparing isoquinolinones and solid forms of isoquinolinones |
EP2982373B1 (en) | 2011-01-19 | 2018-06-13 | Topokine Therapeutics, Inc. | Methods and compostions for reducing body fat |
WO2012103035A1 (en) | 2011-01-24 | 2012-08-02 | Anterios, Inc. | Nanoparticle compositions |
KR20230007537A (en) | 2011-01-24 | 2023-01-12 | 안테리오스, 인코퍼레이티드 | Nanoparticle compositions, formulations thereof, and uses therefor |
JP2014503586A (en) | 2011-01-24 | 2014-02-13 | アンテリオス, インコーポレイテッド | Oil composition |
US8703818B2 (en) | 2011-03-03 | 2014-04-22 | Tersus Pharmaceuticals, LLC | Compositions and methods comprising C16:1n7-palmitoleate |
GB201103836D0 (en) | 2011-03-07 | 2011-04-20 | Glaxosmithkline Biolog Sa | Conjugation process |
US9193767B2 (en) | 2011-03-30 | 2015-11-24 | Brown University | Enopeptins, uses thereof, and methods of synthesis thereto |
AU2012236099A1 (en) | 2011-03-31 | 2013-10-03 | Moderna Therapeutics, Inc. | Delivery and formulation of engineered nucleic acids |
US9067020B2 (en) * | 2011-04-04 | 2015-06-30 | Karim Menassa | Needleless injector wand assembly |
RU2013151159A (en) * | 2011-04-19 | 2015-05-27 | ИНВИЗИДЕРМ, ЭлЭлСи | METHOD FOR CREATING SUBSTANCES THAT OVERSATURATED WITH GAS, DEVICE FOR TRANSDERMAL DELIVERY AND ITS USE |
CN103533953A (en) | 2011-05-17 | 2014-01-22 | 葛兰素史密丝克莱恩生物有限公司 | Vaccine against streptococcus pneumoniae |
ES2627529T3 (en) | 2011-06-08 | 2017-07-28 | Children's Hospital Of Eastern Ontario Research Institute Inc. | Compositions for glioblastoma treatment |
AU2012272815B2 (en) | 2011-06-22 | 2017-09-07 | The General Hospital Corporation | Treatment of proteinopathies |
US8969363B2 (en) | 2011-07-19 | 2015-03-03 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
MX2014000648A (en) | 2011-07-19 | 2014-09-25 | Infinity Pharmaceuticals Inc | Heterocyclic compounds and uses thereof. |
US9115053B2 (en) | 2011-07-22 | 2015-08-25 | Massachusetts Institute Of Technology | Activators of class I histone deacetlyases (HDACS) and uses thereof |
US9408972B2 (en) | 2011-08-02 | 2016-08-09 | Pharmajet, Inc. | Needle-free injection device |
TW201311663A (en) | 2011-08-29 | 2013-03-16 | Infinity Pharmaceuticals Inc | Heterocyclic compounds and uses thereof |
USD681230S1 (en) | 2011-09-08 | 2013-04-30 | Yukon Medical, Llc | Shroud |
SG2014013767A (en) | 2011-09-09 | 2014-05-29 | Lantheus Medical Imaging Inc | Compositions, methods, and systems for the synthesis and use of imaging agents |
WO2013036787A2 (en) | 2011-09-09 | 2013-03-14 | Greenlight Biosciences, Inc. | Cell-free preparation of carbapenems |
EP3384938A1 (en) | 2011-09-12 | 2018-10-10 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
WO2013049332A1 (en) | 2011-09-29 | 2013-04-04 | Infinity Pharmaceuticals, Inc. | Inhibitors of monoacylglycerol lipase and methods of their use |
EP3682905B1 (en) | 2011-10-03 | 2021-12-01 | ModernaTX, Inc. | Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
US20130096170A1 (en) | 2011-10-14 | 2013-04-18 | Hospira, Inc. | Methods of treating pediatric patients using dexmedetomidine |
CA2852468A1 (en) | 2011-10-18 | 2013-04-25 | Aileron Therapeutics, Inc. | Peptidomimetic macrocyles |
US9382239B2 (en) | 2011-11-17 | 2016-07-05 | Dana-Farber Cancer Institute, Inc. | Inhibitors of c-Jun-N-terminal kinase (JNK) |
GB201120000D0 (en) | 2011-11-20 | 2012-01-04 | Glaxosmithkline Biolog Sa | Vaccine |
GB201119999D0 (en) | 2011-11-20 | 2012-01-04 | Glaxosmithkline Biolog Sa | Vaccine |
RU2627632C2 (en) | 2011-12-13 | 2017-08-09 | Фармаджет Инк. | Needle-free intradermal injection device |
CN104114170B (en) | 2011-12-16 | 2021-07-06 | 佛罗里达大学研究基金会 | Use of 4' -deferthionin analogues |
RS63244B1 (en) | 2011-12-16 | 2022-06-30 | Modernatx Inc | Modified mrna compositions |
US8426471B1 (en) | 2011-12-19 | 2013-04-23 | Topokine Therapeutics, Inc. | Methods and compositions for reducing body fat and adipocytes |
US8242158B1 (en) | 2012-01-04 | 2012-08-14 | Hospira, Inc. | Dexmedetomidine premix formulation |
US10130800B2 (en) | 2012-01-27 | 2018-11-20 | Invisiderm, Llc | Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof |
CA2864120A1 (en) | 2012-02-15 | 2013-08-22 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
RU2017145921A (en) | 2012-02-15 | 2019-02-21 | Эйлерон Терапьютикс, Инк. | PEPTIDOMIMETIC MACROCYCLES |
DK2822618T3 (en) | 2012-03-06 | 2024-01-22 | Antares Pharma Inc | Pre-filled needle with breaking force function |
US20150090741A1 (en) * | 2012-03-23 | 2015-04-02 | Ddps Global, Llc | Compression Spring and Pump for Dispensing Fluid |
CA2868459A1 (en) | 2012-03-27 | 2013-10-03 | Amicus Therapeutics, Inc. | Polymorphs of (3r,4r,5s)-5-(difluoromethyl)piperidine-3,4-diol fumarate and uses thereof |
EP2850091A1 (en) | 2012-04-06 | 2015-03-25 | President and Fellows of Harvard College | Methods and compounds for identifying glycosyltransferase inhibitors |
EP2850090B1 (en) | 2012-04-06 | 2018-10-03 | President and Fellows of Harvard College | Chemoenzymatic methods for synthesizing moenomycin analogs |
US9273084B2 (en) | 2012-04-06 | 2016-03-01 | President And Fellows Of Harvard College | Moenomycin analogs, methods of synthesis, and uses thereof |
US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
US10130714B2 (en) | 2012-04-14 | 2018-11-20 | Academia Sinica | Enhanced anti-influenza agents conjugated with anti-inflammatory activity |
USD808010S1 (en) | 2012-04-20 | 2018-01-16 | Amgen Inc. | Injection device |
US9597385B2 (en) | 2012-04-23 | 2017-03-21 | Allertein Therapeutics, Llc | Nanoparticles for treatment of allergy |
EP2846833A4 (en) | 2012-05-10 | 2016-01-06 | Massachusetts Inst Technology | Agents for influenza neutralization |
USD769444S1 (en) | 2012-06-28 | 2016-10-18 | Yukon Medical, Llc | Adapter device |
UA114108C2 (en) | 2012-07-10 | 2017-04-25 | Борд Оф Ріджентс, Дзе Юніверсіті Оф Техас Сістем | Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease |
JP2015521949A (en) * | 2012-07-12 | 2015-08-03 | アンタレス・ファーマ・インコーポレーテッド | Chamfered spike on liquid transfer adapter |
CA2879939A1 (en) | 2012-08-06 | 2014-02-13 | Glaxosmithkline Biologicals S.A. | Novel method |
US20140037680A1 (en) | 2012-08-06 | 2014-02-06 | Glaxosmithkline Biologicals, S.A. | Novel method |
AU2013203000B9 (en) | 2012-08-10 | 2017-02-02 | Lantheus Medical Imaging, Inc. | Compositions, methods, and systems for the synthesis and use of imaging agents |
AU2013306098A1 (en) | 2012-08-18 | 2015-02-12 | Academia Sinica | Cell-permeable probes for identification and imaging of sialidases |
WO2014052647A2 (en) | 2012-09-26 | 2014-04-03 | President And Fellows Of Harvard College | Proline-locked stapled peptides and uses thereof |
US20150225471A1 (en) | 2012-10-01 | 2015-08-13 | President And Fellows Of Harvard College | Stabilized polypeptide insulin receptor modulators |
PT2909204T (en) | 2012-10-12 | 2019-03-21 | Dana Farber Cancer Inst Inc | Gsk3 inhibitors and methods of use thereof |
WO2014063068A1 (en) | 2012-10-18 | 2014-04-24 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
USRE48175E1 (en) | 2012-10-19 | 2020-08-25 | Dana-Farber Cancer Institute, Inc. | Hydrophobically tagged small molecules as inducers of protein degradation |
US10000483B2 (en) | 2012-10-19 | 2018-06-19 | Dana-Farber Cancer Institute, Inc. | Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof |
SI2914296T2 (en) | 2012-11-01 | 2022-01-31 | Infinity Pharmaceuticals, Inc. | Treatment of cancers using pi3 kinase isoform modulators |
BR112015009470A2 (en) | 2012-11-01 | 2019-12-17 | Aileron Therapeutics Inc | disubstituted amino acids and their methods of preparation and use |
WO2014071247A1 (en) | 2012-11-02 | 2014-05-08 | Dana-Farber Cancer Institute, Inc. | Pyrrol-1 -yl benzoic acid derivates useful as myc inhibitors |
SG11201600237YA (en) | 2012-11-21 | 2016-02-26 | Topokine Therapeutics Inc | Methods and compositions for locally increasing body fat |
ES2921623T3 (en) | 2012-11-26 | 2022-08-30 | Modernatx Inc | terminally modified RNA |
WO2014082065A1 (en) | 2012-11-26 | 2014-05-30 | President And Fellows Of Harvard College | Trioxacarcins, trioxacarcin-antibody conjugates, and uses thereof |
WO2014100695A1 (en) | 2012-12-21 | 2014-06-26 | Epizyme, Inc. | Prmt5 inhibitors and uses thereof |
PL2935222T3 (en) | 2012-12-21 | 2019-02-28 | Epizyme Inc | Prmt5 inhibitors and uses thereof |
WO2014100730A1 (en) | 2012-12-21 | 2014-06-26 | Epizyme, Inc. | Prmt5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof |
CA2899363A1 (en) | 2012-12-21 | 2014-06-26 | Epizyme, Inc. | Prmt5 inhibitors and uses thereof |
WO2014113089A2 (en) | 2013-01-17 | 2014-07-24 | Moderna Therapeutics, Inc. | Signal-sensor polynucleotides for the alteration of cellular phenotypes |
WO2014124319A2 (en) | 2013-02-07 | 2014-08-14 | Massachusetts Institute Of Technology | Human adaptation of h5 influenza |
AU2014214844B2 (en) | 2013-02-07 | 2017-12-14 | Children's Medical Center Corporation | Protein antigens that provide protection against pneumococcal colonization and/or disease |
CN105658790A (en) | 2013-02-21 | 2016-06-08 | 东安大略研究所儿童医院有限公司 | Vaccine composition |
WO2014165136A1 (en) | 2013-03-12 | 2014-10-09 | Antares Pharma, Inc. | Constant volume prefilled syringes and kits thereof |
WO2014159813A1 (en) | 2013-03-13 | 2014-10-02 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
KR20150131244A (en) | 2013-03-13 | 2015-11-24 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | Stapled and stitched polypeptides and uses thereof |
US9866924B2 (en) | 2013-03-14 | 2018-01-09 | Immersion Corporation | Systems and methods for enhanced television interaction |
WO2014151386A1 (en) | 2013-03-15 | 2014-09-25 | Infinity Pharmaceuticals, Inc. | Salts and solid forms of isoquinolinones and composition comprising and methods of using the same |
EP2981285B1 (en) | 2013-04-03 | 2020-06-03 | N-Fold Llc | Novel nanoparticle compositions |
JP6437523B2 (en) | 2013-04-04 | 2018-12-12 | プレジデント アンド フェローズ オブ ハーバード カレッジ | Macrolides and methods for their preparation and use |
US9381253B2 (en) | 2013-04-09 | 2016-07-05 | Massachusetts Institute Of Technology | Drug delivery polymer and uses thereof |
WO2014179464A1 (en) | 2013-04-30 | 2014-11-06 | Massachusetts Institute Of Technology | Human adaptation of h3 influenza |
US9315472B2 (en) | 2013-05-01 | 2016-04-19 | Massachusetts Institute Of Technology | 1,3,5-triazinane-2,4,6-trione derivatives and uses thereof |
NO2753788T3 (en) | 2013-05-10 | 2018-06-16 | ||
SG11201509842SA (en) | 2013-05-30 | 2015-12-30 | Infinity Pharmaceuticals Inc | Treatment of cancers using pi3 kinase isoform modulators |
WO2014197723A2 (en) | 2013-06-05 | 2014-12-11 | Massachusetts Institute Of Technology | Human adaptation of h7 ha |
GB2515032A (en) | 2013-06-11 | 2014-12-17 | Cilag Gmbh Int | Guide for an injection device |
GB2517896B (en) | 2013-06-11 | 2015-07-08 | Cilag Gmbh Int | Injection device |
US9212145B2 (en) | 2013-06-11 | 2015-12-15 | Kala Pharmaceuticals, Inc. | Urea derivatives and uses thereof |
GB2515038A (en) | 2013-06-11 | 2014-12-17 | Cilag Gmbh Int | Injection device |
GB2515039B (en) | 2013-06-11 | 2015-05-27 | Cilag Gmbh Int | Injection Device |
CN105492460A (en) | 2013-06-14 | 2016-04-13 | 哈佛大学的校长及成员们 | Stabilized polypeptide insulin receptor modulators |
EP3013365B1 (en) | 2013-06-26 | 2019-06-05 | Academia Sinica | Rm2 antigens and use thereof |
WO2014210564A1 (en) | 2013-06-27 | 2014-12-31 | Academia Sinica | Glycan conjugates and use thereof |
AU2014292888B2 (en) | 2013-07-25 | 2018-03-22 | Dana-Farber Cancer Institute, Inc. | Inhibitors of transcription factors and uses thereof |
EP3492097A1 (en) | 2013-08-05 | 2019-06-05 | GlaxoSmithKline Biologicals S.A. | Combination immunogenic compositions |
BR112016002494A2 (en) | 2013-08-05 | 2017-09-05 | Greenlight Biosciences Inc | PROTEINS CONSTRUCTED WITH A PROTEASE CLEAVAGE SITE, NUCLEIC ACID, VECTOR, CELL AND PROCESS ENGINEERING A RECOMBINANT PROTEIN AND A LARGE NUMBER OF NUCLEIC ACID VARIANTS THAT ENCODE RECOMBINANT PROTEINS |
CN105682666B (en) | 2013-09-06 | 2021-06-01 | 中央研究院 | Activation of human iNKT cells using glycolipids |
NZ718430A (en) | 2013-10-04 | 2021-12-24 | Infinity Pharmaceuticals Inc | Heterocyclic compounds and uses thereof |
US9751888B2 (en) | 2013-10-04 | 2017-09-05 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
US9265881B2 (en) * | 2013-10-14 | 2016-02-23 | Medtronic Minimed, Inc. | Therapeutic agent injection device |
WO2015057894A1 (en) | 2013-10-15 | 2015-04-23 | Massachusetts Institute Of Technology | Methods for treating polycystic kidney disease and polycystic liver disease |
US9902986B2 (en) | 2013-10-16 | 2018-02-27 | Massachusetts Institute Of Technology | Enterobactin conjugates and uses thereof |
US10047070B2 (en) | 2013-10-18 | 2018-08-14 | Dana-Farber Cancer Institute, Inc. | Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7) |
EP3057955B1 (en) | 2013-10-18 | 2018-04-11 | Syros Pharmaceuticals, Inc. | Heteroaromatic compounds useful for the treatment of prolferative diseases |
WO2015061204A1 (en) | 2013-10-21 | 2015-04-30 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
WO2015066482A1 (en) | 2013-11-01 | 2015-05-07 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
WO2015088862A1 (en) | 2013-12-11 | 2015-06-18 | Icu Medical, Inc. | Check valve |
KR20160101162A (en) | 2013-12-24 | 2016-08-24 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | Cortistatin analogues and syntheses and uses thereof |
EP3094352B1 (en) | 2014-01-16 | 2020-09-23 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
US10150818B2 (en) | 2014-01-16 | 2018-12-11 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
JP2017504651A (en) | 2014-01-31 | 2017-02-09 | ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド | Use of diazepan derivatives |
JP2017505350A (en) | 2014-02-12 | 2017-02-16 | アミカス セラピューティックス インコーポレイテッド | Sugar derivatives containing sulfur-containing moieties and methods for their preparation and methods of use for the treatment of MPS IIIC |
EP3119415A4 (en) | 2014-03-07 | 2017-11-29 | The Arizona Board of Regents on behalf of the University of Arizona | Non-narcotic crmp2 peptides targeting sodium channels for chronic pain |
AU2015231413B2 (en) | 2014-03-19 | 2020-04-23 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds for use in the treatment of PI3K-gamma mediated disorders |
TWI687428B (en) | 2014-03-27 | 2020-03-11 | 中央研究院 | Reactive labelling compounds and uses thereof |
ES2868305T3 (en) | 2014-03-28 | 2021-10-21 | Univ Washington Through Its Center For Commercialization | Vaccines against breast and ovarian cancer |
US9675627B2 (en) | 2014-04-14 | 2017-06-13 | Amicus Therapeutics, Inc. | Dosing regimens for treating and/or preventing cerebral amyloidoses |
WO2015164614A1 (en) | 2014-04-23 | 2015-10-29 | Dana-Farber Cancer Institute, Inc. | Janus kinase inhibitors and uses thereof |
US9862688B2 (en) | 2014-04-23 | 2018-01-09 | Dana-Farber Cancer Institute, Inc. | Hydrophobically tagged janus kinase inhibitors and uses thereof |
WO2015168079A1 (en) | 2014-04-29 | 2015-11-05 | Infinity Pharmaceuticals, Inc. | Pyrimidine or pyridine derivatives useful as pi3k inhibitors |
US10195113B2 (en) | 2014-04-30 | 2019-02-05 | Massachusetts Institute Of Technology | Adaptor for removal of fluid from vial using a needle-free syringe |
US10039816B2 (en) | 2014-04-30 | 2018-08-07 | Massachusetts Institute Of Technology | Siderophore-based immunization against gram-negative bacteria |
US10533039B2 (en) | 2014-05-21 | 2020-01-14 | President And Fellows Of Harvard College | Ras inhibitory peptides and uses thereof |
US10118969B2 (en) | 2014-05-27 | 2018-11-06 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
KR20220151036A (en) | 2014-05-27 | 2022-11-11 | 아카데미아 시니카 | Anti-cd20 glycoantibodies and uses thereof |
AU2015267052A1 (en) | 2014-05-27 | 2016-12-15 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
AU2015267045B2 (en) | 2014-05-27 | 2021-02-25 | Academia Sinica | Anti-HER2 glycoantibodies and uses thereof |
US11332523B2 (en) | 2014-05-28 | 2022-05-17 | Academia Sinica | Anti-TNF-alpha glycoantibodies and uses thereof |
JP6664338B2 (en) | 2014-06-13 | 2020-03-13 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | Immunogenic combination |
MA40240B1 (en) | 2014-06-19 | 2019-03-29 | Ariad Pharma Inc | Heteroaryl compounds of kinase inhibition |
WO2015200425A1 (en) | 2014-06-27 | 2015-12-30 | Topokine Therapeutics, Inc. | Topical dosage regimen |
US9840479B2 (en) | 2014-07-02 | 2017-12-12 | Massachusetts Institute Of Technology | Polyamine-fatty acid derived lipidoids and uses thereof |
US10759836B2 (en) | 2014-07-18 | 2020-09-01 | University Of Washington | Cancer vaccine compositions and methods of use thereof |
WO2016025327A1 (en) | 2014-08-10 | 2016-02-18 | Antares Pharma, Inc. | A syringe shock absorber for use in an injection device |
WO2016025643A1 (en) | 2014-08-12 | 2016-02-18 | Massachusetts Institute Of Technology | Brush-poly(glycoamidoamine)-lipids and uses thereof |
CN204033941U (en) * | 2014-08-27 | 2014-12-24 | 北京快舒尔医疗技术有限公司 | A kind of needleless injector with electric functions |
CN107001404B (en) | 2014-09-08 | 2021-06-29 | 中央研究院 | Activation of human iNKT cells using glycolipids |
CN112972378A (en) | 2014-09-24 | 2021-06-18 | 艾瑞朗医疗公司 | Peptidomimetic macrocycles and formulations thereof |
SG11201702223UA (en) | 2014-09-24 | 2017-04-27 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and uses thereof |
US9708348B2 (en) | 2014-10-03 | 2017-07-18 | Infinity Pharmaceuticals, Inc. | Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof |
KR102331856B1 (en) | 2014-10-21 | 2021-11-29 | 다케다 야쿠힌 고교 가부시키가이샤 | Crystalline forms of 5-chloro-n4-[2-(dimethylphosphoryl)phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]pyrimidine-2,4-diamine |
JP2017533238A (en) | 2014-10-28 | 2017-11-09 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | Compositions and methods for antigen-specific tolerance |
EP3041948B1 (en) | 2014-11-10 | 2019-01-09 | Modernatx, Inc. | Alternative nucleic acid molecules containing reduced uracil content and uses thereof |
US10253045B2 (en) | 2014-11-26 | 2019-04-09 | Kala Pharmaceuticals, Inc. | Crystalline forms of a therapeutic compound and uses thereof |
USD786427S1 (en) | 2014-12-03 | 2017-05-09 | Icu Medical, Inc. | Fluid manifold |
USD793551S1 (en) | 2014-12-03 | 2017-08-01 | Icu Medical, Inc. | Fluid manifold |
EP3230272B1 (en) | 2014-12-10 | 2020-08-19 | Kala Pharmaceuticals, Inc. | 1-amino-triazolo(1,5-a)pyridine-substituted urea derivative and uses thereof |
JP7358029B2 (en) | 2014-12-23 | 2023-10-10 | スローン - ケタリング・インスティテュート・フォー・キャンサー・リサーチ | Granaticin B polymorphism |
AU2015371251B2 (en) | 2014-12-23 | 2020-06-11 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (CDK7) |
US9975965B2 (en) | 2015-01-16 | 2018-05-22 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
US10495645B2 (en) | 2015-01-16 | 2019-12-03 | Academia Sinica | Cancer markers and methods of use thereof |
KR20170104617A (en) | 2015-01-24 | 2017-09-15 | 아카데미아 시니카 | Novel glycan conjugates and methods for using them |
BR112017019738A2 (en) | 2015-03-20 | 2018-05-29 | Aileron Therapeutics Inc | peptidomimetic macrocycles and their uses |
WO2016160617A2 (en) | 2015-03-27 | 2016-10-06 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinases |
JP6843065B2 (en) | 2015-03-30 | 2021-03-17 | グリーンライト バイオサイエンシーズ インコーポレーテッドGreenlight Biosciences,Inc. | Cell-free production of ribonucleic acid |
CN107708693A (en) | 2015-04-27 | 2018-02-16 | 佛罗里达大学研究基金会 | Metal-chelator of Metabolic programming and application thereof |
WO2016178591A2 (en) | 2015-05-05 | 2016-11-10 | Gene Predit, Sa | Genetic markers and treatment of male obesity |
EP3307728A4 (en) | 2015-06-12 | 2019-07-17 | Dana Farber Cancer Institute, Inc. | Combination therapy of transcription inhibitors and kinase inhibitors |
CA2990172A1 (en) | 2015-06-19 | 2016-12-22 | Massachusetts Institute Of Technology | Alkenyl substituted 2,5-piperazinediones and their use in compositions for delivering an agent to a subject or cell |
US10059741B2 (en) | 2015-07-01 | 2018-08-28 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
US10179128B2 (en) | 2015-08-31 | 2019-01-15 | Amicus Therapeutics, Inc. | Regimens for treating and preventing lysosomal disorders and degenerative disorders of the central nervous system |
CA2996978A1 (en) | 2015-09-09 | 2017-03-16 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinases |
WO2017044633A1 (en) | 2015-09-10 | 2017-03-16 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles as modulators of mcl-1 |
AU2016324310B2 (en) | 2015-09-17 | 2021-04-08 | Modernatx, Inc. | Compounds and compositions for intracellular delivery of therapeutic agents |
EP3350333B1 (en) | 2015-09-17 | 2021-10-27 | ModernaTX, Inc. | Polynucleotides containing a stabilizing tail region |
US9925170B2 (en) | 2015-10-01 | 2018-03-27 | Kythera Biopharmaceuticals, Inc. | Methods of adipolysis and compositions useful therein |
GB201518684D0 (en) | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vaccine |
CA3004530A1 (en) | 2015-11-07 | 2017-05-11 | Multivir Inc. | Methods and compositions comprising tumor suppressor gene therapy and immune checkpoint blockade for the treatment of cancer |
JP7114465B2 (en) | 2015-12-22 | 2022-08-08 | モデルナティエックス インコーポレイテッド | Compounds and compositions for intracellular delivery of drugs |
AU2017225769B2 (en) | 2016-03-02 | 2023-01-05 | The Board Of Regents Of The University Of Texas System | Sting activating nanovaccine for immunotherapy |
AU2017231749A1 (en) | 2016-03-08 | 2018-09-20 | Academia Sinica | Methods for modular synthesis of N-glycans and arrays thereof |
WO2017161116A1 (en) | 2016-03-17 | 2017-09-21 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors |
CR20180525A (en) | 2016-04-06 | 2019-02-14 | Greenlight Biosciences Inc | RIBONUCLEIC ACID PRODUCTION FREE OF CELLS |
JP7110119B2 (en) | 2016-06-03 | 2022-08-01 | サノフィ パスツール インコーポレイティッド | Modifications of Engineered Influenza Hemagglutinin Polypeptides |
US10105449B2 (en) | 2016-06-07 | 2018-10-23 | Massachusetts Institute Of Technology | Drug delivery polymers and uses thereof |
WO2017214269A1 (en) | 2016-06-08 | 2017-12-14 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
WO2017218704A1 (en) | 2016-06-14 | 2017-12-21 | Modernatx, Inc. | Stabilized formulations of lipid nanoparticles |
GB201610599D0 (en) | 2016-06-17 | 2016-08-03 | Glaxosmithkline Biologicals Sa | Immunogenic Composition |
BR112019001971A2 (en) | 2016-08-05 | 2019-05-07 | Sanofi Pasteur, Inc. | multivalent pneumococcal polysaccharide-protein conjugate composition |
WO2018027123A1 (en) | 2016-08-05 | 2018-02-08 | Sanofi Pasteur, Inc. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
NL2017294B1 (en) | 2016-08-05 | 2018-02-14 | Univ Erasmus Med Ct Rotterdam | Natural cryptic exon removal by pairs of antisense oligonucleotides. |
WO2018035429A1 (en) | 2016-08-18 | 2018-02-22 | Wisconsin Alumni Research Foundation | Peptides that inhibit syndecan-1 activation of vla-4 and igf-1r |
CN109963868B (en) | 2016-08-22 | 2023-11-14 | 醣基生医股份有限公司 | Antibodies, binding fragments, and methods of use |
US10030933B2 (en) * | 2016-08-25 | 2018-07-24 | Thomas Gore Living Trust | Gas spring assembly and a catch therefor |
KR101838631B1 (en) * | 2016-11-03 | 2018-04-26 | 서울대학교 산학협력단 | Automatic recharging micro-jet drug injection device preventing jet speed down problem of repeated injection |
US11583504B2 (en) | 2016-11-08 | 2023-02-21 | Modernatx, Inc. | Stabilized formulations of lipid nanoparticles |
KR101863355B1 (en) * | 2016-12-01 | 2018-06-01 | 한국기계연구원 | A Pressure-Increasing Needle Free Syringe for Variable Injection |
WO2018106738A1 (en) | 2016-12-05 | 2018-06-14 | Massachusetts Institute Of Technology | Brush-arm star polymers, conjugates and particles, and uses thereof |
AU2017375958A1 (en) | 2016-12-12 | 2019-07-04 | Multivir Inc. | Methods and compositions comprising viral gene therapy and an immune checkpoint inhibitor for treatment and prevention of cancer and infectious diseases |
CA3045043A1 (en) | 2016-12-31 | 2018-07-05 | Bioxcel Therapeutics, Inc. | Use of sublingual dexmedetomidine for the treatment of agitation |
CA3055653A1 (en) | 2017-03-15 | 2018-09-20 | Modernatx, Inc. | Lipid nanoparticle formulation |
AU2018234692B2 (en) | 2017-03-15 | 2022-06-02 | Modernatx, Inc. | Compounds and compositions for intracellular delivery of therapeutic agents |
US11555031B2 (en) | 2017-03-20 | 2023-01-17 | The Broad Institute, Inc. | Compounds and methods for regulating insulin secretion |
BR112019020810A2 (en) | 2017-04-05 | 2020-04-28 | Biogen Ma Inc | tricyclic compounds as glycogen synthase kinase 3 (gsk3) inhibitors and uses thereof |
BR112019022009A2 (en) | 2017-04-21 | 2020-05-12 | Sillajen, Inc. | VACCINIA ONCOLYTIC VIRUS COMBINATION THERAPY AND CHECK POINT INHIBITOR |
EP3615509A1 (en) | 2017-04-25 | 2020-03-04 | Amicus Therapeutics, Inc. | Novel compositions for preventing and/or treating degenerative disorders of the central nervous system and/or lysosomal storage disorders |
EP3638678A1 (en) | 2017-06-14 | 2020-04-22 | Modernatx, Inc. | Compounds and compositions for intracellular delivery of agents |
US11612647B2 (en) | 2017-06-23 | 2023-03-28 | University Of Maryland, Baltimore | Immunogenic compositions |
WO2019013790A1 (en) | 2017-07-12 | 2019-01-17 | Curza Global, Llc | Antimicrobial compounds and uses thereof |
WO2019013789A1 (en) | 2017-07-12 | 2019-01-17 | Curza Global, Llc | Antimicrobial compounds |
CN111164410B (en) | 2017-07-27 | 2024-03-29 | 生物梅里埃有限公司 | Separating tube |
MX2020002348A (en) | 2017-08-31 | 2020-10-08 | Modernatx Inc | Methods of making lipid nanoparticles. |
CA3078726A1 (en) | 2017-10-11 | 2019-04-18 | Greenlight Biosciences, Inc. | Methods and compositions for nucleoside triphosphate and ribonucleic acid production |
EP3717033A4 (en) | 2017-12-01 | 2021-08-25 | North Carolina State University | Fibrin particles and methods of making the same |
WO2019124852A1 (en) | 2017-12-19 | 2019-06-27 | 조민수 | Needleless injection syringe |
GB201721582D0 (en) | 2017-12-21 | 2018-02-07 | Glaxosmithkline Biologicals Sa | S aureus antigens and immunogenic compositions |
GB201721576D0 (en) | 2017-12-21 | 2018-02-07 | Glaxosmithkline Biologicals Sa | Hla antigens and glycoconjugates thereof |
CN112313339A (en) | 2018-01-05 | 2021-02-02 | 渥太华医院研究所 | Modified vaccinia vector |
KR20200135986A (en) | 2018-03-19 | 2020-12-04 | 멀티비르 인코포레이티드 | Methods and compositions for cancer treatment comprising tumor suppressor gene therapy and CD122/CD132 agonists |
JP2021529756A (en) | 2018-06-27 | 2021-11-04 | バイオエクセル セラピューティクス,インコーポレイテッド | Film preparation containing dexmedetomidine and its preparation method |
JP7410135B2 (en) | 2018-09-19 | 2024-01-09 | モデルナティエックス インコーポレイテッド | Compounds and compositions for intracellular delivery of therapeutic agents |
WO2020061457A1 (en) | 2018-09-20 | 2020-03-26 | Modernatx, Inc. | Preparation of lipid nanoparticles and methods of administration thereof |
US11160791B2 (en) | 2018-11-01 | 2021-11-02 | Medefil, Inc. | Dexmedetomidine injection premix formulation in ready to use (RTU) bags |
EP3903858A4 (en) * | 2018-12-27 | 2022-10-26 | Daicel Corporation | Needleless syringe |
CN113924292A (en) | 2019-01-16 | 2022-01-11 | 库扎环球有限责任公司 | Antimicrobial compounds and methods |
US20230072397A1 (en) | 2019-01-16 | 2023-03-09 | Curza Global, Llc | Antimicrobial Compounds and Methods |
CN111481774B (en) * | 2019-01-25 | 2023-06-09 | 凯联医疗科技(上海)有限公司 | Needleless syringe for trace medicine |
CA3128215A1 (en) | 2019-01-31 | 2020-08-06 | Modernatx, Inc. | Methods of preparing lipid nanoparticles |
WO2020168466A1 (en) | 2019-02-19 | 2020-08-27 | Stemirna Therapeutics Co., Ltd. | Modified nucleoside and synthetic methods thereof |
AU2020316013A1 (en) | 2019-07-19 | 2022-02-17 | Arx, Llc | Non-sedating dexmedetomidine treatment regimens |
JP2022543773A (en) | 2019-07-31 | 2022-10-14 | モデルナティエックス インコーポレイテッド | Compositions and methods for delivery of RNA interfering agents to immune cells |
KR20220042378A (en) | 2019-07-31 | 2022-04-05 | 사노피 파스퇴르 인코포레이티드 | Polyvalent pneumococcal polysaccharide-protein conjugate composition and method of use thereof |
KR102269721B1 (en) * | 2019-08-13 | 2021-06-28 | 주식회사 쿼드메디슨 | Micro-needle bullet injection apparaus for endoscope |
JP2023501575A (en) | 2019-11-13 | 2023-01-18 | カーザ グローバル, エルエルシー | Antimicrobial compounds and methods |
WO2021113644A1 (en) | 2019-12-05 | 2021-06-10 | Multivir Inc. | Combinations comprising a cd8+ t cell enhancer, an immune checkpoint inhibitor and radiotherapy for targeted and abscopal effects for the treatment of cancer |
US11752269B2 (en) * | 2019-12-18 | 2023-09-12 | Integrimedical Llc | Spring loaded medical needle-free injection system |
TW202139976A (en) | 2020-01-31 | 2021-11-01 | 美商現代公司 | Methods of preparing lipid nanoparticles |
WO2021173965A1 (en) | 2020-02-28 | 2021-09-02 | Massachusetts Institute Of Technology | Identification of variable influenza residues and uses thereof |
US20230136095A1 (en) * | 2020-04-30 | 2023-05-04 | Beijing Qs Medical Technology Co., Ltd. | Injection head of needleless syringe, needleless syringe body and needleless syringe |
WO2021231729A1 (en) | 2020-05-13 | 2021-11-18 | Sanofi | Adjuvanted stabilized stem hemagglutinin nanoparticles and methods of using the same to induce broadly neutralizing antibodies against influenza |
JPWO2022092294A1 (en) | 2020-10-30 | 2022-05-05 | ||
JPWO2022092295A1 (en) | 2020-10-30 | 2022-05-05 | ||
AR124267A1 (en) | 2020-12-09 | 2023-03-01 | Genentech Inc | HIGH THROUGH METHODS FOR PREPARING LIPID NANOPARTICLES AND THEIR USES |
WO2022192176A1 (en) | 2021-03-09 | 2022-09-15 | Massachusetts Institute Of Technology | Branched poly(-amino esters) for the delivery of nucleic acids |
TW202313065A (en) | 2021-05-28 | 2023-04-01 | 美商季卡尼醫療公司 | Compounds for treating genetic diseases |
CN113318301A (en) * | 2021-06-28 | 2021-08-31 | 北京科技大学 | Large-dose porous needleless injector |
WO2023018817A1 (en) | 2021-08-11 | 2023-02-16 | Sanofi Pasteur Inc. | Truncated influenza neuraminidase and methods of using the same |
WO2023039108A1 (en) | 2021-09-08 | 2023-03-16 | Affinivax, Inc. | Coronavirus vaccine |
TW202333778A (en) | 2021-10-08 | 2023-09-01 | 美商賽諾菲巴斯德公司 | Multivalent influenza vaccines |
WO2023079113A1 (en) | 2021-11-05 | 2023-05-11 | Sanofi | Hybrid multivalent influenza vaccines comprising hemagglutinin and neuraminidase and methods of using the same |
WO2023081798A1 (en) | 2021-11-05 | 2023-05-11 | Sanofi Pasteur Inc. | Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods of using the same |
TW202333654A (en) | 2021-12-16 | 2023-09-01 | 美商現代公司 | Processes for preparing lipid nanoparticles |
GB2614309A (en) | 2021-12-24 | 2023-07-05 | Stratosvir Ltd | Improved vaccinia virus vectors |
WO2023129963A1 (en) | 2021-12-30 | 2023-07-06 | Curza Global, Llc | Antimicrobial compounds and methods |
WO2023144206A1 (en) | 2022-01-27 | 2023-08-03 | Sanofi Pasteur | Modified vero cells and methods of using the same for virus production |
WO2023144393A1 (en) | 2022-01-28 | 2023-08-03 | Fundació Centre De Regulació Genòmica | Therapeutic cytokines and methods |
US11524105B1 (en) * | 2022-03-03 | 2022-12-13 | Hetaida Technology Co., Ltd. | Nasal aspirator capable of effectively preventing backflow and control method thereof |
WO2023177577A1 (en) | 2022-03-14 | 2023-09-21 | Sanofi Pasteur Inc. | Machine-learning techniques in protein design for vaccine generation |
WO2023193002A1 (en) | 2022-04-01 | 2023-10-05 | Modernatx, Inc. | Cross mixers for lipid nanoparticle production, and methods of operating the same |
WO2023235380A1 (en) | 2022-06-01 | 2023-12-07 | Zikani Therapeutics, Inc. | Macrolides for treating genetic diseases |
CN114870163B (en) * | 2022-06-06 | 2023-12-19 | 江苏乐聚医药科技有限公司 | Air spring mixed needleless injector |
WO2023250513A1 (en) | 2022-06-24 | 2023-12-28 | Zikani Therapeutics, Inc. | 13-membered macrolide compounds for treating diseases mediated by abnormal protein translation |
WO2024026487A1 (en) | 2022-07-29 | 2024-02-01 | Modernatx, Inc. | Lipid nanoparticle compositions comprising phospholipid derivatives and related uses |
WO2024026475A1 (en) | 2022-07-29 | 2024-02-01 | Modernatx, Inc. | Compositions for delivery to hematopoietic stem and progenitor cells (hspcs) and related uses |
WO2024026482A1 (en) | 2022-07-29 | 2024-02-01 | Modernatx, Inc. | Lipid nanoparticle compositions comprising surface lipid derivatives and related uses |
WO2024049994A1 (en) | 2022-09-01 | 2024-03-07 | Zikani Therapeutics, Inc. | Treatment of familial adenomatous polyopsis using a 13-membered macrolide |
CN115429974B (en) * | 2022-09-07 | 2023-09-15 | 北京快舒尔医疗技术有限公司 | Needleless injector |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2254153A1 (en) * | 1972-11-04 | 1974-05-09 | Werner Dipl Ing Kullmann | Automatic universally applicable hypodermic syringe - for veterinary treat-ment of animals or for drugging them at long range |
US4507113A (en) * | 1982-11-22 | 1985-03-26 | Derata Corporation | Hypodermic jet injector |
US4561856A (en) * | 1983-08-18 | 1985-12-31 | Cochran Ulrich D | Infusion pump |
WO1990001961A1 (en) * | 1988-08-30 | 1990-03-08 | Injet Medical Products, Inc. | Gas-pressure-regulated needleless injection system |
US5062830A (en) * | 1990-04-04 | 1991-11-05 | Derata Corporation | Dry disposable nozzle assembly for medical jet injector |
EP0499481A1 (en) * | 1991-02-15 | 1992-08-19 | Waverley Pharmaceutical Limited | Transfer adaptors |
DE4129271C1 (en) * | 1991-09-03 | 1992-09-17 | Fresenius Ag, 6380 Bad Homburg, De | |
US5193517A (en) * | 1990-06-08 | 1993-03-16 | Utec B.V. | Gas spring airgun |
US5279576A (en) * | 1992-05-26 | 1994-01-18 | George Loo | Medication vial adapter |
Family Cites Families (167)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3123070A (en) * | 1964-03-03 | Multidose jet injector | ||
US489757A (en) * | 1893-01-10 | eeilly | ||
US396107A (en) * | 1889-01-15 | Fluid speed-regulator for elevators | ||
US2704543A (en) * | 1955-03-22 | Hypo jet injector | ||
US489727A (en) * | 1893-01-10 | Suspender-end | ||
US1567517A (en) * | 1924-10-20 | 1925-12-29 | Roy D Kisbey | Shock absorber |
US1973706A (en) * | 1928-11-30 | 1934-09-18 | Hawley Jones Corp | Shock absorber |
US2322244A (en) * | 1940-03-18 | 1943-06-22 | Marshall L Lockhart | Hypodermic injector |
US2390246A (en) * | 1940-10-18 | 1945-12-04 | Marvin L Folkman | Syringe |
US2380534A (en) * | 1941-04-26 | 1945-07-31 | Marshall L Lockhart | Hypodermic injector |
US2322245A (en) * | 1943-05-20 | 1943-06-22 | Marshall L Lockhart | Ypodermic injector and method of use thereof |
US2413303A (en) * | 1944-01-17 | 1946-12-31 | Marvin L Folkman | Syringe |
US2459875A (en) * | 1944-09-11 | 1949-01-25 | Marvin L Folkman | Syringe and ampoule |
US2398544A (en) * | 1945-01-06 | 1946-04-16 | Marshall L Lockhart | Hypodermic injector |
US2450527A (en) * | 1945-10-27 | 1948-10-05 | P & V Quicklocking Co | Semiautomatic coupling |
US2800903A (en) * | 1947-07-30 | 1957-07-30 | Becton Dickinson Co | Injection apparatus |
US2605763A (en) * | 1948-01-31 | 1952-08-05 | Becton Dickinson Co | Injection device |
US2547099A (en) * | 1948-03-11 | 1951-04-03 | Becton Dickinson Co | Injection device and ampoule |
US2704542A (en) * | 1949-02-21 | 1955-03-22 | Scherer Corp R P | Jet therapy method |
US2688968A (en) * | 1949-05-14 | 1954-09-14 | Scherer Corp R P | Hypo jet ampoule |
US2902994A (en) * | 1949-05-21 | 1959-09-08 | Scherer Corp R P | Hypo jet injector |
US2699166A (en) * | 1949-07-29 | 1955-01-11 | Becton Dickinson Co | Hypodermic injection unit |
US2737946A (en) * | 1949-09-01 | 1956-03-13 | Jr George N Hein | Hypodermic injection apparatus |
US2798485A (en) * | 1949-09-01 | 1957-07-09 | Jr George N Hein | Ampule |
US2653602A (en) * | 1950-06-17 | 1953-09-29 | Becton Dickinson Co | Injection device |
US2754818A (en) * | 1950-06-24 | 1956-07-17 | Scherer Corp R P | Hypo jet injector |
US2671347A (en) * | 1950-06-24 | 1954-03-09 | Scherer Corp R P | Latch structure |
US2681653A (en) * | 1950-09-06 | 1954-06-22 | Becton Dickinson Co | Hypodermic injection orifice structure and method of making same |
US2670121A (en) * | 1951-01-31 | 1954-02-23 | Scherer Corp R P | Flexible follower for metal ampoules |
US2764977A (en) * | 1951-05-24 | 1956-10-02 | Becton Dickinson Co | Hypodermic injection mechanism |
US2635602A (en) * | 1951-11-21 | 1953-04-21 | Jr George N Hein | Hypodermic injection apparatus |
US2821193A (en) * | 1952-07-22 | 1958-01-28 | Geoffrey W Walker | Multiple injection inoculator instrument |
US2789839A (en) * | 1952-08-27 | 1957-04-23 | Bissell Carpet Sweeper Co | Spring detent engaging means for carpet sweeper sectional handle |
US2717597A (en) * | 1952-12-04 | 1955-09-13 | Jr George N Hein | Injection apparatus |
GB766431A (en) * | 1953-02-11 | 1957-01-23 | Nat Res Dev | Improvements relating to hypodermic injection apparatus |
FR1067076A (en) * | 1953-12-16 | 1954-06-11 | Hygiene Scient Hygiscient Lab | Improvements to needleless parenteral injection devices |
US2820655A (en) * | 1953-12-18 | 1958-01-21 | Collins Radio Co | Tenacious fastener |
US2798486A (en) * | 1953-12-21 | 1957-07-09 | Jr George N Hein | Injection assembly |
US2714887A (en) * | 1954-04-26 | 1955-08-09 | Scherer Corp R P | Intradermal injector |
US2816544A (en) * | 1954-07-12 | 1957-12-17 | Scherer Corp R P | Hypodermic injector |
US2816543A (en) * | 1954-07-12 | 1957-12-17 | Scherer Corp R P | Hypodermic injector |
US2821981A (en) * | 1954-07-21 | 1958-02-04 | Geoffrey W Walker | Multi-shot inoculant injector instrument with adjustable ejection pressure control |
US2825332A (en) * | 1954-08-20 | 1958-03-04 | Howard Johnson Electrostatics | Hypodermic syringe with magnetically actuated piston and needle |
US2762370A (en) * | 1954-09-07 | 1956-09-11 | Scherer Corp R P | Hypodermic injector |
US2762369A (en) * | 1954-09-07 | 1956-09-11 | Scherer Corp R P | Hypodermic injector with adjustable impact plunger |
US3147967A (en) * | 1956-06-27 | 1964-09-08 | Bougeard Arthur | Pneumatic shock absorber |
NL106573C (en) * | 1957-05-31 | |||
US2928390A (en) * | 1957-07-15 | 1960-03-15 | Scherer Corp R P | Multi-dose hypodermic injector |
US3057349A (en) * | 1959-12-14 | 1962-10-09 | Ismach Aaron | Multi-dose jet injection device |
GB964585A (en) * | 1960-03-23 | |||
GB995605A (en) * | 1960-08-04 | 1965-06-23 | Amalgamated Dental Co Ltd | Improvements relating to hypodermic injection apparatus |
NL268186A (en) * | 1960-08-15 | |||
FR1072399A (en) * | 1961-01-07 | 1954-09-13 | Intra-dermal injector | |
US3138157A (en) * | 1961-05-12 | 1964-06-23 | Z & W Mfg Corp | Inoculant injector instrument |
US3167071A (en) * | 1961-07-17 | 1965-01-26 | Scherer Corp R P | Apparatus for administering intradermal injections |
US3115133A (en) * | 1962-05-15 | 1963-12-24 | Morando Emilio Donald | Needleless prefilled disposable hypodermic injector |
NL296017A (en) * | 1962-08-03 | 1900-01-01 | ||
BE643768A (en) * | 1963-02-18 | |||
US3140713A (en) * | 1963-03-25 | 1964-07-14 | Ismach Aaron | Intradermal nozzle for jet injection devices |
US3202151A (en) * | 1963-04-08 | 1965-08-24 | Scherer Corp R P | Multidose jet injector |
US3330276A (en) * | 1963-10-07 | 1967-07-11 | Scherer Corp R P | Hypodermic jet injector |
US3245703A (en) * | 1963-10-28 | 1966-04-12 | Robert S Manly | Quick detachable pipe coupling |
US3335722A (en) * | 1963-11-01 | 1967-08-15 | Olin Mathieson | Hypodermic device |
US3308818A (en) * | 1964-07-24 | 1967-03-14 | Eugene V Rutkowski | Injection cartridge |
US3330277A (en) * | 1964-08-17 | 1967-07-11 | Scherer Corp R P | Multidose hypodermic injector |
US3292622A (en) * | 1964-09-21 | 1966-12-20 | Oscar H Banker | Power operated inoculator |
US3406684A (en) * | 1964-09-28 | 1968-10-22 | Yuryo Kikakuhin Kenkyusho Kk | Jet type, medical injection instrument |
US3399759A (en) * | 1964-11-19 | 1968-09-03 | Express Injector Company Ltd | Protecting holders |
US3353537A (en) * | 1965-08-11 | 1967-11-21 | George W Knox | Automatic multi-dosage inoculating instrument |
US3424154A (en) * | 1965-11-08 | 1969-01-28 | Charles W Kinsley | Injection system |
US3461867A (en) * | 1966-03-14 | 1969-08-19 | Mizzy Inc | Needleless injector |
US3526225A (en) * | 1967-03-31 | 1970-09-01 | Tokyo Sokuhan Kk | Jet-type hypodermic injection device |
US3527212A (en) * | 1967-09-13 | 1970-09-08 | Wesley D Clark | Disposable needleless hypodermic injector |
US3490451A (en) * | 1967-11-13 | 1970-01-20 | Scherer Corp R P | Hypodermic jet injector nozzle |
US3521633A (en) * | 1967-11-13 | 1970-07-28 | Scherer Corp R P | Brake device for hypodermic jet injector |
US3476110A (en) * | 1967-11-13 | 1969-11-04 | Scherer Corp R P | Crank for loading hypodermic jet injector |
US3518990A (en) * | 1968-05-02 | 1970-07-07 | Oscar H Banker | Gun type inoculator |
US3507276A (en) * | 1968-08-28 | 1970-04-21 | Murray B Burgess | Jet injector |
US3561443A (en) * | 1968-09-06 | 1971-02-09 | Oscar H Banker | Inoculator gun with delayed action |
US3557784A (en) * | 1968-12-24 | 1971-01-26 | Walter A Shields | Syringe |
US3625208A (en) * | 1969-05-19 | 1971-12-07 | Mediquip Corp | Apparatus for pressure-administering medicaments |
US3688765A (en) * | 1969-10-03 | 1972-09-05 | Jack S Gasaway | Hypodermic injection device |
US3659587A (en) * | 1970-06-30 | 1972-05-02 | Affiliated Hospital Prod | Valved connector arrangement |
US3838689A (en) * | 1970-11-04 | 1974-10-01 | M Cohen | Disposable syringe with slit valve |
US3714943A (en) * | 1970-12-01 | 1973-02-06 | H Yanof | Medicament injectors |
US3805783A (en) * | 1971-02-12 | 1974-04-23 | A Ismach | Hand powered hypodermic jet injector gun |
US3783895A (en) * | 1971-05-04 | 1974-01-08 | Sherwood Medical Ind Inc | Universal parenteral fluid administration connector |
US3768472A (en) * | 1972-02-07 | 1973-10-30 | M Hodosh | Fluid dispensing gun |
US3779371A (en) * | 1972-03-13 | 1973-12-18 | W Rovinski | Package of separated materials to be mixed |
US3782380A (en) * | 1973-01-04 | 1974-01-01 | Gaast H V D | Medicament injecting device |
US3827601A (en) * | 1973-03-23 | 1974-08-06 | J Magrath | Hand powered liquid dispenser of the metering type |
US3908651A (en) * | 1974-05-17 | 1975-09-30 | Daystrol Scient Inc | Medicament injection device |
US3938520A (en) * | 1974-06-10 | 1976-02-17 | Abbott Laboratories | Transfer unit having a dual channel transfer member |
US3945379A (en) * | 1974-08-08 | 1976-03-23 | Smithkline Corporation | Injection device |
US3945383A (en) * | 1974-08-08 | 1976-03-23 | Smithkline Corporation | Unit dose ampul for jet injector |
JPS51130094A (en) * | 1975-05-08 | 1976-11-12 | Asahi Chemical Ind | Twoostage pressure injector |
US4141675A (en) * | 1975-12-22 | 1979-02-27 | Physics International Company | Gas-actuated fuel pump wherein the pump piston is driven by a spring |
US4089334A (en) * | 1976-10-07 | 1978-05-16 | Schwebel Paul R | Pyrotechnically powered needleless injector |
DE2817102C2 (en) * | 1978-04-19 | 1985-01-24 | Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG, 6380 Bad Homburg | Connector for plastic cannulas or venous catheters |
US4328802A (en) * | 1980-05-14 | 1982-05-11 | Survival Technology, Inc. | Wet dry syringe package |
GB2084704B (en) | 1980-10-01 | 1983-06-29 | Theobald David Reginald | Air rifle |
US4373559A (en) * | 1980-12-04 | 1983-02-15 | Abbott Laboratories | Apparatus for pressurizing an additive transfer device |
JPS57103947A (en) * | 1980-12-18 | 1982-06-28 | Kuroda Precision Ind Ltd | Pneumatic shock absorber |
US4421508A (en) * | 1981-02-24 | 1983-12-20 | Cohen Edgar C | Vacuum-compression injector |
US4436519A (en) | 1981-05-28 | 1984-03-13 | Argon Medical Corp. | Removable hemostasis valve |
US4447225A (en) * | 1982-03-22 | 1984-05-08 | Taff Barry E | Multidose jet injector |
CA1178503A (en) | 1982-05-27 | 1984-11-27 | Health-Mor Personal Care Corporation | Needleless hypodermic injector |
US4505709A (en) * | 1983-02-22 | 1985-03-19 | Froning Edward C | Liquid transfer device |
US4518385A (en) * | 1983-06-13 | 1985-05-21 | Preci-Tech Ltd. | Disposable syringe for needleless injector |
HU186718B (en) | 1983-06-29 | 1985-09-30 | Radelkis Electrokemiai | Automatic needleless syringe operable by cardox cylinder suitable for personal giving injection e.g. insulin |
DE3444817A1 (en) | 1984-01-20 | 1985-07-25 | Rasmussen Gmbh, 6457 Maintal | CONNECTOR |
US4619651A (en) | 1984-04-16 | 1986-10-28 | Kopfer Rudolph J | Anti-aerosoling drug reconstitution device |
US4588403A (en) | 1984-06-01 | 1986-05-13 | American Hospital Supply Corporation | Vented syringe adapter assembly |
US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
GB2173287B (en) | 1985-04-01 | 1988-08-10 | Utec Bv | Air weapon air compression system |
US4675020A (en) | 1985-10-09 | 1987-06-23 | Kendall Mcgaw Laboratories, Inc. | Connector |
US4662878A (en) | 1985-11-13 | 1987-05-05 | Patents Unlimited Ltd. | Medicine vial adaptor for needleless injector |
US4680027A (en) | 1985-12-12 | 1987-07-14 | Injet Medical Products, Inc. | Needleless hypodermic injection device |
US4744786A (en) | 1986-06-17 | 1988-05-17 | Cordis Corporation | Infusion pump |
EP0250022A3 (en) | 1986-06-17 | 1988-06-22 | SICIM SpA | Portable endermic injector |
US4753316A (en) | 1986-06-26 | 1988-06-28 | Hydroacoustics Inc. | Seismic source |
US4722728A (en) | 1987-01-23 | 1988-02-02 | Patents Unlimited, Ltd. | Needleless hypodermic injector |
IT1217047B (en) | 1987-03-19 | 1990-03-14 | Cocchi Pietro | INJECTION SYRINGE, INTRAVENOUS SPECIES, MADE TO BE USED ONLY ONCE, WITHOUT POSSIBILITY OF RE-INSPIRATION. |
USD304616S (en) | 1987-04-30 | 1989-11-14 | Derata Corporation | Medicament injector |
US4940460A (en) | 1987-06-19 | 1990-07-10 | Bioject, Inc. | Patient-fillable and non-invasive hypodermic injection device assembly |
US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
US4768568A (en) | 1987-07-07 | 1988-09-06 | Survival Technology, Inc. | Hazardous material vial apparatus providing expansible sealed and filter vented chambers |
US4874367A (en) | 1988-02-05 | 1989-10-17 | Marpam International, Inc. | Hypodermic jet injector and cartridge therefor |
US5073165A (en) | 1988-02-05 | 1991-12-17 | Marpam International, Inc. | Hypodermic jet injector and cartridge therefor |
ES2036714T3 (en) | 1988-03-25 | 1993-06-01 | Dematex Development & Trading Inc. C/O Quijano And Associates | TUBE, PLUG AND COMPRESSION RING FOR BLOOD SAMPLING SYSTEMS. |
DE8806642U1 (en) | 1988-05-20 | 1988-09-08 | Stabilus Gmbh, 5400 Koblenz, De | |
DE3818811A1 (en) | 1988-06-03 | 1989-12-14 | Stabilus Gmbh | GAS SPRING WITH SEVERAL PRESSURE SPACES |
US4950240A (en) | 1988-10-04 | 1990-08-21 | Greenwood Eugene C | Hypodermic syringe for single use |
JPH02212768A (en) | 1989-02-13 | 1990-08-23 | Terumo Corp | Blood sampling tube |
US5188599A (en) | 1989-07-11 | 1993-02-23 | Med-Design, Inc. | Retractable needle system |
DE3923513A1 (en) | 1989-07-15 | 1991-01-24 | Stabilus Gmbh | METHOD AND DEVICE FOR INLETING PRESSURE GAS IN THE CONTAINER TUBE OF A PNEUMATIC SPRING OR THE LIKE |
CA1325149C (en) | 1989-08-31 | 1993-12-14 | Gavin Mcgregor | Variable intensity remote controlled needleless injector |
US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
AU6550990A (en) | 1989-11-09 | 1991-05-16 | Bioject, Inc. | Needleless hypodermic injection device |
US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
US5031266A (en) | 1989-12-21 | 1991-07-16 | Whirlpool Corporation | Vacuum cleaner wand seal |
US4989905A (en) | 1990-02-05 | 1991-02-05 | Lamson & Sessions Co. | Fitting for corrugated tubing |
GB9017007D0 (en) | 1990-08-02 | 1990-09-19 | Bernard Derek J C | Improvements to pre-charged pneumatic airguns |
GB9020749D0 (en) | 1990-09-24 | 1990-11-07 | Bates William T D | Improved single-use syringe |
DE4038010A1 (en) | 1990-11-29 | 1992-06-04 | Stabilus Gmbh | HYDRAULICALLY ADJUSTABLE STEERING COLUMN |
CA2032830C (en) | 1990-12-20 | 1994-07-26 | Robert Graham Straghan | Coupling |
US5085332B1 (en) | 1991-04-11 | 1994-04-05 | Gettig Technologies Inc | Closure assembly |
IL98036A0 (en) | 1991-05-02 | 1992-06-21 | Yoav Cohen | Plastic stand pipe support for load-bearing adjustable piston |
GB9118204D0 (en) | 1991-08-23 | 1991-10-09 | Weston Terence E | Needle-less injector |
US5356380A (en) | 1991-10-23 | 1994-10-18 | Baxter International Inc. | Drug delivery system |
US5181912A (en) | 1991-12-05 | 1993-01-26 | Roy Hammett | Non-reusable syringe |
US5209362A (en) | 1992-01-24 | 1993-05-11 | Lutzker Robert S | Can resealer |
US5165560A (en) | 1992-03-26 | 1992-11-24 | Genesis Industries, Inc. | Nonrotating hermetically sealed closure for bottle containing liquid |
US5312577A (en) | 1992-05-08 | 1994-05-17 | Bioject Inc. | Method for manufacturing an ampule |
JP2931715B2 (en) | 1992-05-12 | 1999-08-09 | 三菱電機株式会社 | Resin sealing method, resin sealing device, and gas spring |
JPH05317383A (en) | 1992-05-19 | 1993-12-03 | Nissho Corp | Solution container equipped with means for communicating with chemical container |
US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
USD349958S (en) | 1992-07-24 | 1994-08-23 | Bioject Inc. | Needleless injector |
US5304128A (en) | 1992-09-22 | 1994-04-19 | Habley Medical Technology Corporation | Gas powered self contained syringe |
AU5293393A (en) | 1992-09-28 | 1994-04-26 | Equidyne Systems, Incorporated | Hypodermic jet injector |
US5569189A (en) | 1992-09-28 | 1996-10-29 | Equidyne Systems, Inc. | hypodermic jet injector |
US5334144A (en) | 1992-10-30 | 1994-08-02 | Becton, Dickinson And Company | Single use disposable needleless injector |
US5292308A (en) | 1993-05-04 | 1994-03-08 | Ryan Dana W | Three piece intravenous line connector |
US5344125A (en) | 1993-09-17 | 1994-09-06 | Diebolt International, Inc. | Gas spring with filler valve |
US5352203A (en) | 1994-03-31 | 1994-10-04 | Vallelunga Anthony J | Aspirating non-reuseable syringe |
US5509912A (en) | 1994-10-24 | 1996-04-23 | Vlv Associates | Connector |
-
1995
- 1995-01-09 US US08/369,812 patent/US5599302A/en not_active Expired - Lifetime
-
1996
- 1996-01-11 DE DE69627474T patent/DE69627474D1/en not_active Expired - Lifetime
- 1996-01-11 EP EP96902588A patent/EP0802809B1/en not_active Expired - Lifetime
- 1996-01-11 AU AU46935/96A patent/AU4693596A/en not_active Abandoned
- 1996-01-11 AT AT96902588T patent/ATE237380T1/en not_active IP Right Cessation
- 1996-01-11 JP JP52172796A patent/JPH10512165A/en not_active Ceased
- 1996-01-11 WO PCT/US1996/000086 patent/WO1996021482A2/en active IP Right Grant
- 1996-01-25 TW TW85100851A patent/TW387814B/en active
-
1997
- 1997-01-09 US US08/780,918 patent/US5846233A/en not_active Expired - Lifetime
- 1997-01-09 US US08/780,917 patent/US5891085A/en not_active Expired - Fee Related
- 1997-01-09 US US08/780,920 patent/US5919159A/en not_active Expired - Fee Related
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2254153A1 (en) * | 1972-11-04 | 1974-05-09 | Werner Dipl Ing Kullmann | Automatic universally applicable hypodermic syringe - for veterinary treat-ment of animals or for drugging them at long range |
US4507113A (en) * | 1982-11-22 | 1985-03-26 | Derata Corporation | Hypodermic jet injector |
US4561856A (en) * | 1983-08-18 | 1985-12-31 | Cochran Ulrich D | Infusion pump |
WO1990001961A1 (en) * | 1988-08-30 | 1990-03-08 | Injet Medical Products, Inc. | Gas-pressure-regulated needleless injection system |
US5062830A (en) * | 1990-04-04 | 1991-11-05 | Derata Corporation | Dry disposable nozzle assembly for medical jet injector |
US5193517A (en) * | 1990-06-08 | 1993-03-16 | Utec B.V. | Gas spring airgun |
EP0499481A1 (en) * | 1991-02-15 | 1992-08-19 | Waverley Pharmaceutical Limited | Transfer adaptors |
DE4129271C1 (en) * | 1991-09-03 | 1992-09-17 | Fresenius Ag, 6380 Bad Homburg, De | |
US5279576A (en) * | 1992-05-26 | 1994-01-18 | George Loo | Medication vial adapter |
Cited By (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5769138A (en) * | 1996-04-01 | 1998-06-23 | Medi-Ject Corporation | Nozzle and adapter for loading medicament into an injector |
JP2009056339A (en) * | 1998-07-27 | 2009-03-19 | Antares Pharma Inc | Jet injector |
EP1100566A1 (en) * | 1998-07-27 | 2001-05-23 | Medi-Ject Corporation | Loading mechanism for medical injector assembly |
EP1100566A4 (en) * | 1998-07-27 | 2002-03-20 | Medi Ject Corp | Loading mechanism for medical injector assembly |
JP2000107289A (en) * | 1998-10-05 | 2000-04-18 | Showa Yakuhin Kako Kk | Cartridge type dental syringe unit |
US9737670B2 (en) | 2002-02-11 | 2017-08-22 | Antares Pharma, Inc. | Intradermal injector |
US9629959B2 (en) | 2005-01-24 | 2017-04-25 | Antares Pharma, Inc. | Prefilled syringe jet injector |
US11446441B2 (en) | 2005-01-24 | 2022-09-20 | Antares Pharma, Inc. | Prefilled syringe injector |
US10478560B2 (en) | 2005-01-24 | 2019-11-19 | Antares Pharma, Inc. | Prefilled syringe injector |
WO2007131025A1 (en) * | 2006-05-03 | 2007-11-15 | Antares Pharma, Inc. | Injector with adjustable dosing |
US11547808B2 (en) | 2006-05-03 | 2023-01-10 | Antares Pharma, Inc. | Two-stage reconstituting injector |
US9808582B2 (en) | 2006-05-03 | 2017-11-07 | Antares Pharma, Inc. | Two-stage reconstituting injector |
US10688250B2 (en) | 2006-05-03 | 2020-06-23 | Antares Pharma, Inc. | Two-stage reconstituting injector |
EP2023981A1 (en) * | 2006-06-07 | 2009-02-18 | Acushot Inc. | Charging mechanism for a needle-free injector |
EP2023981A4 (en) * | 2006-06-07 | 2014-09-03 | Acushot Inc | Charging mechanism for a needle-free injector |
US8764753B2 (en) | 2007-02-14 | 2014-07-01 | Depuy Mitek Inc. | Implement for orientating a tool, particularly useful in surgical tools for harvesting and implanting bone plugs to repair damaged bone tissue |
WO2009111794A1 (en) * | 2008-03-07 | 2009-09-11 | Pharmajet, Inc. | Intradermal injector and uses thereof |
US10864324B2 (en) | 2008-05-20 | 2020-12-15 | Avant Medical Corp. | Autoinjector system |
US11883633B2 (en) | 2008-05-20 | 2024-01-30 | Avant Medical Corp. | Autoinjector system |
US8177749B2 (en) | 2008-05-20 | 2012-05-15 | Avant Medical Corp. | Cassette for a hidden injection needle |
US10792426B2 (en) | 2008-05-20 | 2020-10-06 | Avant Medical Corp. | Autoinjector system |
US9925336B2 (en) | 2008-05-20 | 2018-03-27 | Avant Medical Corp. | Cassette for a hidden injection needle |
US9974904B2 (en) | 2008-05-20 | 2018-05-22 | Avant Medical Corp. | Autoinjector system |
US8052645B2 (en) | 2008-07-23 | 2011-11-08 | Avant Medical Corp. | System and method for an injection using a syringe needle |
US11724032B2 (en) | 2008-07-23 | 2023-08-15 | Avant Medical Corp. | System and method for an injection using a syringe needle |
US9616173B2 (en) | 2008-07-23 | 2017-04-11 | Avant Medical Corporation | System and method for an injection using a syringe needle |
US10639422B2 (en) | 2008-07-23 | 2020-05-05 | Avant Medical Corp. | System and method for an injection using a syringe needle |
US11497753B2 (en) | 2009-03-20 | 2022-11-15 | Antares Pharma, Inc. | Hazardous agent injection system |
US9750881B2 (en) | 2009-03-20 | 2017-09-05 | Antares Pharma, Inc. | Hazardous agent injection system |
US10555954B2 (en) | 2009-03-20 | 2020-02-11 | Antares Pharma, Inc. | Hazardous agent injection system |
WO2012085579A3 (en) * | 2010-12-22 | 2012-08-16 | Owen Mumford Limited | Autoinjectors |
US10092706B2 (en) | 2011-04-20 | 2018-10-09 | Amgen Inc. | Autoinjector apparatus |
US11419990B2 (en) | 2011-04-20 | 2022-08-23 | Amgen Inc. | Autoinjector apparatus |
US10918805B2 (en) | 2011-04-20 | 2021-02-16 | Amgen Inc. | Autoinjector apparatus |
US10279131B2 (en) | 2011-07-15 | 2019-05-07 | Antares Pharma, Inc. | Injection device with cammed RAM assembly |
US10568809B2 (en) | 2011-07-15 | 2020-02-25 | Ferring B.V. | Liquid-transfer adapter beveled spike |
US10821072B2 (en) | 2012-04-06 | 2020-11-03 | Antares Pharma, Inc. | Needle assisted jet injection administration of testosterone compositions |
US11771646B2 (en) | 2012-04-06 | 2023-10-03 | Antares Pharma, Inc. | Needle assisted jet injection administration of testosterone compositions |
US9950125B2 (en) | 2012-04-06 | 2018-04-24 | Antares Pharma, Inc. | Needle assisted jet injection administration of testosterone compositions |
USD898908S1 (en) | 2012-04-20 | 2020-10-13 | Amgen Inc. | Pharmaceutical product cassette for an injection device |
US11446440B2 (en) | 2012-05-07 | 2022-09-20 | Antares Pharma, Inc. | Needle assisted injection device having reduced trigger force |
US10357609B2 (en) | 2012-05-07 | 2019-07-23 | Antares Pharma, Inc. | Needle assisted jet injection device having reduced trigger force |
US10905827B2 (en) | 2012-05-07 | 2021-02-02 | Antares Pharma, Inc. | Injection device with cammed ram assembly |
US9744302B2 (en) | 2013-02-11 | 2017-08-29 | Antares Pharma, Inc. | Needle assisted jet injection device having reduced trigger force |
US10881798B2 (en) | 2013-02-11 | 2021-01-05 | Antares Pharma, Inc. | Needle assisted injection device having reduced trigger force |
US11813435B2 (en) | 2013-02-11 | 2023-11-14 | Antares Pharma, Inc. | Needle assisted injection device having reduced trigger force |
US11628260B2 (en) | 2013-03-11 | 2023-04-18 | Antares Pharma, Inc. | Multiple dosage injector with rack and pinion dosage system |
US10610649B2 (en) | 2013-03-11 | 2020-04-07 | Antares Pharma, Inc. | Multiple dosage injector with rack and pinion dosage system |
US9707354B2 (en) | 2013-03-11 | 2017-07-18 | Antares Pharma, Inc. | Multiple dosage injector with rack and pinion dosage system |
US10492990B2 (en) | 2013-03-15 | 2019-12-03 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
US11020537B2 (en) | 2013-03-15 | 2021-06-01 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
US10092703B2 (en) | 2013-03-15 | 2018-10-09 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
US10786629B2 (en) | 2013-03-15 | 2020-09-29 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
US11944798B2 (en) | 2013-03-15 | 2024-04-02 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
US10894130B2 (en) | 2015-04-10 | 2021-01-19 | Daicel Corporation | Syringe |
Also Published As
Publication number | Publication date |
---|---|
AU4693596A (en) | 1996-07-31 |
EP0802809B1 (en) | 2003-04-16 |
TW387814B (en) | 2000-04-21 |
US5599302A (en) | 1997-02-04 |
EP0802809A2 (en) | 1997-10-29 |
US5919159A (en) | 1999-07-06 |
DE69627474D1 (en) | 2003-05-22 |
US5891085A (en) | 1999-04-06 |
WO1996021482A3 (en) | 1996-09-12 |
US5846233A (en) | 1998-12-08 |
ATE237380T1 (en) | 2003-05-15 |
JPH10512165A (en) | 1998-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5891085A (en) | Nozzle assembly with lost motion connection for medical injector assembly | |
JP3487856B2 (en) | Needleless syringe | |
US10099011B2 (en) | Needle-less injector and method of fluid delivery | |
US5704911A (en) | Needleless hypodermic jet injector | |
CA2259560C (en) | Hypodermic jet injector | |
JP4153503B2 (en) | Carpul used for retractable dental syringes | |
US5499972A (en) | Hypodermic jet injector | |
US5697917A (en) | Nozzle assembly with adjustable plunger travel gap | |
US6673034B2 (en) | Gas power sources for a needle-less injector and needle-less injectors incorporating the same | |
US5062830A (en) | Dry disposable nozzle assembly for medical jet injector | |
EP1237598B1 (en) | Medical injector and medicament loading system for use therewith | |
US5024656A (en) | Gas-pressure-regulated needleless injection system | |
WO1997031665A1 (en) | Nozzle assembly with adjustable plunger travel gap | |
US7044931B2 (en) | Syringe with retractable needle assembly | |
WO1997031664A1 (en) | Frangible plunger for nozzle assembly | |
CA2394351C (en) | Syringe with retractable needle assembly | |
WO2002066097A2 (en) | Method and apparatus for inhibiting fluid loss from a syringe | |
CA2021566A1 (en) | Needleless injector |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AU AZ BB BG BR BY CA CN CZ EE FI GE HU IS JP KG KP KR KZ LK LR LS LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK TJ TM TR TT UA US UZ VN AZ BY KZ RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1996902588 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1996902588 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWG | Wipo information: grant in national office |
Ref document number: 1996902588 Country of ref document: EP |